Podcasts about Johns Hopkins

atlantic financial times empires johns hopkins etats unis 2026 matins kim ghattas guillaume erner

Play Episode Listen Later Dec 6, 2025 55:25

In his weekly clinical update, Dr. Griffin and Vincent Racaniello discuss the positive side effect of the shingles vaccine on dementia outcomes and how one dose of the HPV vaccine is non-inferior to two doses, but are dismayed about the FDA's secrecy around the inflammatory statement that the COVID-19 vaccine is linked to the death of 10 children. Dr. Griffin then deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, effectiveness of maternal administration of the RVS vaccine or the COVID vaccine for neonates, where to find PEMGARDA, how to access and pay for Paxlovid, long COVID treatment center, where to go for answers to your long COVID questions, how celiac plexus blocks improves gastrointestinal long COVID symptoms, brain alterations and neurodegenerative processes in long COVID cognitive impairment and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode The effect of shingles vaccination at different stages of the dementia disease course (Cell) FDA links 10 children's deaths to COVID-19 vaccines. Doctors want proof (ABC News) Subject: Deaths in children due to COVID-19 vaccines and CBER's path forward Dear Team CBER,(Washington Post) Noninferiority of One HPV Vaccine Dose to Two Doses(NEJM) Marburg Outbreak in Ethiopia: Current Situation (CDC: Marburg Virus Disease) Washington state resident believed to be the first to die from a rare strain of bird flu (AP News) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Measles (CDC Measles (Rubeola)) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: cliff notes (CDC FluView) ACIP Recommendations Summary (CDC: Influenza) Types of Influenza Viruses (CDC: Influenza (flu)) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season(FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Maternal and Neonatal Outcomes After Respiratory Syncytial Virus Prefusion F Protein Vaccination During Pregnancy (Obstetrics & Gynecology) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Effectiveness of COVID-19 vaccines against post-COVID-19 condition/long COVID: systematic review and meta-analysis (CMI: Clinical Microbiology and Infection) SARS-CoV-2Infection Versus Vaccination During Pregnancy: Implications for Placental Antibody Transfer (The Pediatric Infectious Disease Journal) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Case Report: Celiac plexus block improves gastrointestinal Long COVID symptoms (Frontiers Neuroscience) Distinct brain alterations and neurodegenerative processes in cognitive impairment associated with post-acute sequelae of COVID-19 (Nature Communications) Reaching out to US house representative Letters read on TWiV 1276 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

2026 : l'année des empires ?

Les matins

Play Episode Listen Later Dec 5, 2025 16:59

durée : 00:16:59 - L'Invité(e) des Matins - par : Guillaume Erner, Yoann Duval - 2026 sera-t-elle l'année des empires ? Et si la question était plutôt : quelles formes prendront les empires en 2026 ? - réalisation : Félicie Faugère - invités : Henry Farrell professeur de relations internationales à l'université Johns Hopkins aux Etats-Unis; Kim Ghattas journaliste libano-néerlandaise. Collaboratrice du magazine The Atlantic et éditrice au Financial Times

Thu Episode #2152: AI: The Trillion-Dollar Wealth Heist

The David Knight Show

Play Episode Listen Later Dec 4, 2025 181:57 Transcription Available

00:10:21 — Trump Declares Biden's Autopen Orders Invalid Knight breaks down Trump's claim that all autopen-signed Biden documents are void, warning this could unleash unprecedented legal and political chaos. 00:13:40 — Trump Will Never Go After Fauci Knight argues Trump cannot revoke Fauci-related decisions because he still embraces Operation Warp Speed and refuses to acknowledge vaccine harm. 00:15:14 — Rare-Earth Crisis Caused by U.S. Policy Failures Knight details how America lost control of rare-earth production due to political corruption, EPA restrictions, and China's strategic long-term planning. 00:37:44 — AEI & Johns Hopkins Exposed for Designing Lockdowns Knight reacts to evidence that AEI and Johns Hopkins crafted the original U.S. lockdown strategy — revealing the establishment origins of the Covid regime. 00:44:55 — Autopsies Show Vaccine Injury Across Multiple Organs Knight reviews new pathology data demonstrating widespread organ damage linked to mRNA vaccines, challenging official narratives on vaccine safety. 00:47:19 — Global Spike in Kidney Failure After Vaccination Knight highlights dramatic rises in fatal renal injury across multiple countries, calling it one of the clearest indicators of vaccine-associated harm. 00:58:24 — MIT Predicts AI Will Erase 20 Million U.S. Jobs Knight explains MIT's model showing that AI could immediately wipe out one-eighth of American employment, triggering a corporate-engineered depression. 00:59:10 — AI Job Loss Becomes a Trillion-Dollar Wealth Transfer Knight argues AI isn't replacing workers for efficiency but to funnel $1.2 trillion in wages upward to corporate elites. 01:06:38 — Anthropic's “AI Soul” Document Reveals Transhumanist Agenda Knight exposes how AI developers deliberately push the idea of machine consciousness to manipulate public perception and normalize post-human ideology. 01:14:37 — Businesses Abandon AI After Failure to Deliver Results Knight shows Census Bureau data revealing steep declines in AI adoption, demonstrating widespread disillusionment after years of hype. 02:03:03 — Billionaire Silver Purchase Exposes Fragile Supply Chain Tony reveals a single $500M silver order stressed dealers nationwide, proving how thin and unstable the physical silver market has become. 02:08:56 — National Silver Supply Crisis: Mining Cannot Meet Demand Knight and Tony explain how global silver production is collapsing even as industrial and governmental demand soars, creating unstoppable upward pressure on prices. Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silver For 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHT Find out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-david-knight-show--2653468/support.

Thu Episode #2152: AI: The Trillion-Dollar Wealth Heist

The REAL David Knight Show

Play Episode Listen Later Dec 4, 2025 181:57 Transcription Available

Resistance Psychologist Says Trump Won't Finish His Term — "The Dementia Cliff Is Coming"

The Comedy Cellar: Live from the Table

Play Episode Listen Later Dec 4, 2025 76:15

An Explosive Debate on Trump's Brain. Dr. John Gartner, former Johns Hopkins psychiatry faculty member and a vocal critic of Donald Trump, joins Live From the Table. We challenge Gartner directly on his claims that Donald Trump is exhibiting malignant narcissism, psychopathy, and accelerating dementia. The debate spans science, politics, ethics, medical bias, and the media's treatment of both Trump and Biden. This episode includes extended transcript-verified clips, counter-arguments, and some of the most heated exchanges we've aired. Chapters below. Chapters 00:00 – Intro: Who is Dr. John Gartner? 01:00 – Goldwater Rule & Diagnosing Public Figures 03:20 – Trump, Narcissism & Malignant Personality Disorders 07:00 – Is Trump a Psychopath? Criminality, Lying & Abuse 11:20 – Noam Pushes Back: What Counts as Evidence? 14:15 – The Dementia Question: Language, Gait & Decline 16:55 – “He's Not the Same Man”: Claims From Former Officials 18:45 – Noam's Counterargument: Bolton, Kelly, McMaster, Woodward 22:30 – Cognitive Decline vs. Strategy: What's Real? 26:05 – Trump's Speeches Examined: Word Salad or Something Else? 29:30 – The “Skedaddle” Story & Loose Associations 33:00 – Kamala Harris, Biden & Claims of Asymmetrical Scrutiny 37:10 – Debate Clips: Biden Then vs. Now, Trump Then vs. Now 41:50 – Variability & Sundowning: How Dementia Presents 45:00 – Trump's Stamina vs. Trump's Disorganization 48:20 – Is This Cognitive Decline or Just Aging? 52:00 – Impulsivity, National Security & Dangerous Decision-Making 56:10 – The Hakeem Jeffries “Very Nice Man” Story 59:00 – Biden Wandering Clips & Why the Medical Community Stayed Silent 1:02:00 – Is Medical Bias Real? Noam Pushes Gartner 1:04:00 – Would Trump's Inner Circle Have Noticed Decline? 1:07:00 – Narcissism, Children & Why His Family Keeps Distance 1:10:00 – “Do You Feel Sympathy for Him?” 1:14:00 – Closing Thoughts & Invitation to Visit the Cellar

How to Save Science Funding

Statecraft

Play Episode Listen Later Dec 4, 2025 60:50

If you're a scientist, and you apply for federal research funding, you'll ask for a specific dollar amount. Let's say you're asking for a million-dollar grant. Your grant covers the direct costs, things like the salaries of the researchers that you're paying. If you get that grant, your university might get an extra $500,000. That money is called “indirect costs,” but think of it as overhead: that money goes to lab space, to shared equipment, and so on.This is the system we've used to fund American research infrastructure for more than 60 years. But earlier this year, the Trump administration proposed capping these payments at just 15% of direct costs, way lower than current indirect cost rates. There are legal questions about whether the admin can do that. But if it does, it would force universities to fundamentally rethink how they do science.The indirect costs system is pretty opaque from the outside. Is the admin right to try and slash these indirect costs? Where does all that money go? And if we want to change how we fund research overhead, what are the alternatives? How do you design a research system to incentivize the research you actually wanna see in the world?I'm joined today by Pierre Azoulay from MIT Sloan and Dan Gross from Duke's Fuqua School of Business. Together with Bhaven Sampat at Johns Hopkins, they conducted the first comprehensive empirical study of how indirect costs actually work. Earlier this year, I worked with them to write up that study as a more accessible policy brief for IFP. They've assembled data on over 350 research institutions, and they found some striking results. While negotiated rates often exceed 50-60%, universities actually receive much less, due to built-in caps and exclusions.Moreover, the institutions that would be hit hardest by proposed cuts are those whose research most often leads to new drugs and commercial breakthroughs.Thanks to Katerina Barton, Harry Fletcher-Wood, and Inder Lohla for their help with this episode, and to Beez for her help on the charts.Let's say I'm a researcher at a university and I apply for a federal grant. I'm looking at cancer cells in mice. It will cost me $1 million to do that research — to pay grad students, to buy mice and test tubes. I apply for a grant from the National Institutes of Health, or NIH. Where do indirect costs come in?Dan Gross: Research generally incurs two categories of costs, much as business operations do.* Direct or variable costs are typically project-specific; they include salaries and consumable supplies.* Indirect or fixed costs are not as easily assigned to any particular project. [They include] things like lab space, data and computing resources, biosecurity, keeping the lights on and the buildings cooled and heated — even complying with the regulatory requirements the federal government imposes on researchers. They are the overhead costs of doing research.Pierre Azoulay: You will use those grad students, mice, and test tubes, the direct costs. But you're also using the lab space. You may be using a shared facility where the mice are kept and fed. Pieces of large equipment are shared by many other people to conduct experiments. So those are fixed costs from the standpoint of your research project.Dan: Indirect Cost Recovery (ICR) is how the federal government has been paying for the fixed cost of research for the past 60 years. This has been done by paying universities institution-specific fixed percentages on top of the direct cost of the research. That's the indirect cost rate. That rate is negotiated by institutions, typically every two to four years, supported by several hundred pages of documentation around its incurred costs over the recent funding cycle.The idea is to compensate federally funded researchers for the investments, infrastructure, and overhead expenses related to the research they perform for the government. Without that funding, universities would have to pay those costs out of pocket and, frankly, many would not be interested or able to do the science the government is funding them to do.Imagine I'm doing my mouse cancer science at MIT, Pierre's parent institution. Some time in the last four years, MIT had this negotiation with the National Institutes of Health to figure out what the MIT reimbursable rate is. But as a researcher, I don't have to worry about what indirect costs are reimbursable. I'm all mouse research, all day.Dan: These rates are as much of a mystery to the researchers as it is to the public. When I was junior faculty, I applied for an external grant from the National Science Foundation (NSF) — you can look up awards folks have won in the award search portal. It doesn't break down indirect and direct cost shares of each grant. You see the total and say, “Wow, this person got $300,000.” Then you go to write your own grant and realize you can only budget about 60% of what you thought, because the rest goes to overhead. It comes as a bit of a shock the first time you apply for grant funding.What goes into the overhead rates? Most researchers and institutions don't have clear visibility into that. The process is so complicated that it's hard even for those who are experts to keep track of all the pieces.Pierre: As an individual researcher applying for a project, you think about the direct costs of your research projects. You're not thinking about the indirect rate. When the research administration of your institution sends the application, it's going to apply the right rates.So I've got this $1 million experiment I want to run on mouse cancer. If I get the grant, the total is $1.5 million. The university takes that .5 million for the indirect costs: the building, the massive microscope we bought last year, and a tiny bit for the janitor. Then I get my $1 million. Is that right?Dan: Duke University has a 61% indirect cost rate. If I propose a grant to the NSF for $100,000 of direct costs — it might be for data, OpenAI API credits, research staff salaries — I would need to budget an extra $61,000 on top for ICR, bringing the total grant to $161,000.My impression is that most federal support for research happens through project-specific grants. It's not these massive institutional block grants. Is that right?Pierre: By and large, there aren't infrastructure grants in the science funding system. There are other things, such as center grants that fund groups of investigators. Sometimes those can get pretty large — the NIH grant for a major cancer center like Dana-Farber could be tens of millions of dollars per year.Dan: In the past, US science funding agencies did provide more funding for infrastructure and the instrumentation that you need to perform research through block grants. In the 1960s, the NSF and the Department of Defense were kicking up major programs to establish new data collection efforts — observatories, radio astronomy, or the Deep Sea Drilling project the NSF ran, collecting core samples from the ocean floor around the world. The Defense Advanced Research Projects Agency (DARPA) — back then the Advanced Research Projects Agency (ARPA) — was investing in nuclear test detection to monitor adherence to nuclear test ban treaties. Some of these were satellite observation methods for atmospheric testing. Some were seismic measurement methods for underground testing. ARPA supported the installation of a network of seismic monitors around the world. Those monitors are responsible for validating tectonic plate theory. Over the next decade, their readings mapped the tectonic plates of the earth. That large-scale investment in research infrastructure is not as common in the US research policy enterprise today.That's fascinating. I learned last year how modern that validation of tectonic plate theory was. Until well into my grandparents' lifetime, we didn't know if tectonic plates existed.Dan: Santi, when were you born?1997.Dan: So I'm a good decade older than you — I was born in 1985. When we were learning tectonic plate theory in the 1990s, it seemed like something everybody had always known. It turns out that it had only been known for maybe 25 years.So there's this idea of federal funding for science as these massive pieces of infrastructure, like the Hubble Telescope. But although projects like that do happen, the median dollar the Feds spend on science today is for an individual grant, not installing seismic monitors all over the globe.Dan: You applied for a grant to fund a specific project, whose contours you've outlined in advance, and we provided the funding to execute that project.Pierre: You want to do some observations at the observatory in Chile, and you are going to need to buy a plane ticket — not first class, not business class, very much economy.Let's move to current events. In February of this year, the NIH announced it was capping indirect cost reimbursement at 15% on all grants.What's the administration's argument here?Pierre: The argument is there are cases where foundations only charge 15% overhead rate on grants — and universities acquiesce to such low rates — and the federal government is entitled to some sort of “most-favored nation” clause where no one pays less in overhead than they pay. That's the argument in this half-a-page notice. It's not much more elaborate than that.The idea is, the Gates Foundation says, “We will give you a grant to do health research and we're only going to pay 15% indirect costs.” Some universities say, “Thank you. We'll do that.” So clearly the universities don't need the extra indirect cost reimbursement?Pierre: I think so.Dan: Whether you can extrapolate from that to federal research funding is a different question, let alone if federal research was funding less research and including even less overhead. Would foundations make up some of the difference, or even continue funding as much research, if the resources provided by the federal government were lower? Those are open questions. Foundations complement federal funding, as opposed to substitute for it, and may be less interested in funding research if it's less productive.What are some reasons that argument might be misguided?Pierre: First, universities don't always say, “Yes” [to a researcher wishing to accept a grant]. At MIT, getting a grant means getting special authorization from the provost. That special authorization is not always forthcoming. The provost has a special fund, presumably funded out of the endowment, that under certain conditions they will dip into to make up for the missing overhead.So you've got some research that, for whatever reason, the federal government won't fund, and the Gates Foundation is only willing to fund it at this low rate, and the university has budgeted a little bit extra for those grants that it still wants.Pierre: That's my understanding. I know that if you're going to get a grant, you're going to have to sit in many meetings and cajole any number of administrators, and you don't always get your way.Second, it's not an apples-to-apples comparison [between federal and foundation grants] because there are ways to budget an item as a direct cost in a foundation grant that the government would consider an indirect cost. So you might budget some fractional access to a facility…Like the mouse microscope I have to use?Pierre: Yes, or some sort of Cryo-EM machine. You end up getting more overhead through the back door.The more fundamental way in which that approach is misguided is that the government wants its infrastructure — that it has contributed to through [past] indirect costs — to be leveraged by other funders. It's already there, it's been paid for, it's sitting idle, and we can get more bang for our buck if we get those additional funders to piggyback on that investment.Dan: That [other funders] might not be interested in funding otherwise.Why wouldn't they be interested in funding it otherwise? What shouldn't the federal government say, “We're going to pay less. If it's important research, somebody else will pay for it.”Dan: We're talking about an economies-of-scale problem. These are fixed costs. The more they're utilized, the more the costs get spread over individual research projects.For the past several decades, the federal government has funded an order of magnitude more university research than private firms or foundations. If you look at NSF survey data, 55% of university R&D is federally funded; 6% is funded by foundations. That is an order of magnitude difference. The federal government has the scale to support and extract value for whatever its goals are for American science.We haven't even started to get into the administrative costs of research. That is part of the public and political discomfort with indirect-cost recovery. The idea that this is money that's going to fund university bloat.I should lay my cards on the table here for readers. There are a ton of problems with the American scientific enterprise as it currently exists. But when you look at studies from a wide range of folks, it's obvious that R&D in American universities is hugely valuable. Federal R&D dollars more than pay for themselves. I want to leave room for all critiques of the scientific ecosystem, of the universities, of individual research ideas. But at this 30,000-foot level, federal R&D dollars are well spent.Dan: The evidence may suggest that, but that's not where the political and public dialogue around science policy is. Again, I'm going to bring in a long arc here. In the 1950s and 1960s, it was, “We're in a race with the Soviet Union. If we want to win this race, we're going to have to take some risky bets.” And the US did. It was more flexible with its investments in university and industrial science, especially related to defense aims. But over time, with the waning of these political pressures and with new budgetary pressures, the tenor shifted from, “Let's take chances” to “Let's make science and other parts of government more accountable.” The undercurrent of Indirect Cost Recovery policy debates has more of this accountability framing.This comes up in this comparison to foundation rates: “Is the government overpaying?” Clearly universities are willing to accept less from foundations. It comes up in this perception that ICR is funding administrative growth that may not be productive or socially efficient. Accountability seems to be a priority in the current day.Where are we right now [August 2025] on that 15% cap on indirect costs?Dan: Recent changes first kicked off on February 7th, when NIH posted its supplemental guidance, that introduced a policy that the direct cost rates that it paid on its grants would be 15% to institutions of higher education. That policy was then adopted by the NSF, the DOD, and the Department of Energy. All of these have gotten held up in court by litigation from universities. Things are stuck in legal limbo. Congress has presented its point of view that, “At least for now, I'd like to keep things as they are.” But this has been an object of controversy long before the current administration even took office in January. I don't think it's going away.Pierre: If I had to guess, the proposal as it first took shape is not what is going to end up being adopted. But the idea that overhead rates are an object of controversy — are too high, and need to be reformed — is going to stay relevant.Dan: Partly that's because it's a complicated issue. Partly there's not a real benchmark of what an appropriate Indirect Cost Recovery policy should be. Any way you try to fund the cost of research, you're going to run into trade-offs. Those are complicated.ICR does draw criticism. People think it's bloated or lacks transparency. We would agree some of these critiques are well-founded. Yet it's also important to remember that ICR pays for facilities and administration. It doesn't just fund administrative costs, which is what people usually associate it with. The share of ICR that goes to administrative costs is legally capped at 26% of direct costs. That cap has been in place since 1991. Many universities have been at that cap for many years — you can see this in public records. So the idea that indirect costs are going up over time, and that that's because of bloat at US universities, has to be incorrect, because the administrative rate has been capped for three decades.Many of those costs are incurred in service of complying with regulations that govern research, including the cost of administering ICR to begin with. Compiling great proposals every two to four years and a new round of negotiations — all of that takes resources. Those are among the things that indirect cost funding reimburses.Even then, universities appear to under-recover their true indirect costs of federally-sponsored research. We have examples from specific universities which have reported detailed numbers. That under-recovery means less incentive to invest in infrastructure, less capacity for innovation, fewer clinical trials. So there's a case to be made that indirect cost funding is too low.Pierre: The bottom line is we don't know if there is under- or over-recovery of indirect costs. There's an incentive for university administrators to claim there's under-recovery. So I take that with a huge grain of salt.Dan: It's ambiguous what a best policy would look like, but this is all to say that, first, public understanding of this complex issue is sometimes a bit murky. Second, a path forward has to embrace the trade-offs that any particular approach to ICR presents.From reading your paper, I got a much better sense that a ton of the administrative bloat of the modern university is responding to federal regulations on research. The average researcher reports spending almost half of their time on paperwork. Some of that is a consequence of the research or grant process; some is regulatory compliance.The other thing, which I want to hear more on, is that research tools seem to be becoming more expensive and complex. So the microscope I'm using today is an order of magnitude more expensive than the microscope I was using in 1950. And you've got to recoup those costs somehow.Pierre: Everything costs more than it used to. Research is subject to Baumol's cost disease. There are areas where there's been productivity gains — software has had an impact.The stakes are high because, if we get this wrong, we're telling researchers that they should bias the type of research they're going to pursue and training that they're going to undergo, with an eye to what is cheaper. If we reduce the overhead rate, we should expect research that has less fixed cost and more variable costs to gain in favor — and research that is more scale-intensive to lose favor. There's no reason for a benevolent social planner to find that a good development. The government should be neutral with respect to the cost structure of research activities. We don't know in advance what's going to be more productive.Wouldn't a critic respond, “We're going to fund a little bit of indirect costs, but we're not going to subsidize stuff that takes huge amounts of overhead. If universities want to build that fancy new telescope because it's valuable, they'll do it.” Why is that wrong when it comes to science funding?Pierre: There's a grain of truth to it.Dan: With what resources though? Who's incentivized to invest in this infrastructure? There's not a paid market for science. Universities can generate some licensing fees from patents that result from science. But those are meager revenue streams, realistically. There are reasons to believe that commercial firms are under-incentivized to invest in basic scientific research. Prior to 1940, the scientific enterprise was dramatically smaller because there wasn't funding the way that there is today. The exigencies of war drew the federal government into funding research in order to win. Then it was productive enough that folks decided we should keep doing it. History and economic logic tells us that you're not going to see as much science — especially in these fixed-cost heavy endeavors — when those resources aren't provided by the public.Pierre: My one possible answer to the question is, “The endowment is going to pay for it.” MIT has an endowment, but many other universities do not. What does that mean for them? The administration also wants to tax the heck out of the endowment.This is a good opportunity to look at the empirical work you guys did in this great paper. As far as I can tell, this was one of the first real looks at what indirect costs rates look like in real life. What did you guys find?Dan: Two decades ago, Pierre and Bhaven began collecting information on universities' historical indirect cost rates. This is a resource that was quietly sitting on the shelf waiting for its day. That day came this past February. Bhaven and Pierre collected information on negotiated ICR rates for the past 60 years. During this project, we also collected the most recent versions of those agreements from university websites to bring the numbers up to the current day.We pulled together data for around 350 universities and other research institutions. Together, they account for around 85% of all NIH research funding over the last 20 years.We looked at their:* Negotiated indirect cost rates, from institutional indirect cost agreements with the government, and their;* Effective rates [how much they actually get when you look at grant payments], using NIH grant funding data.Negotiated cost rates have gone up. That has led to concerns that the overhead cost of research is going up — these claims that it's funding administrative bloat. But our most important finding is that there's a large gap between the sticker rates — the negotiated ICR rates that are visible to the public, and get floated on Twitter as examples of university exorbitance — and the rates that universities are paid in practice, at least on NIH grants; we think it's likely the case for NSF and other agency grants too.An institution's effective ICR funding rates are much, much lower than their negotiated rates and they haven't changed much for 40 years. If you look at NIH's annual budget, the share of grant funding that goes to indirect costs has been roughly constant at 27-28% for a long time. That implies an effective rate of around 40% over direct costs. Even though many institutions have negotiated rates of 50-70%, they usually receive 30-50%.The difference between those negotiated rates and the effective rates seems to be due to limits and exceptions built into NIH grant rules. Those rules exclude some grants, such as training grants, from full indirect cost funding. They also exclude some direct costs from the figure used to calculate ICR rates. The implication is that institutions receive ICR payments based on a smaller portion of their incurred direct costs than typically assumed. As the negotiated direct cost falls, you see a university being paid a higher indirect cost rate off a smaller — modified — direct cost base, to recover the same amount of overhead.Is it that the federal government is saying for more parts of the grant, “We're not going to reimburse that as an indirect cost.”?Dan: This is where we shift a little bit from assessment to speculation. What's excluded from total direct costs? One thing is researcher salaries above a certain level.What is that level? Can you give me a dollar amount?Dan: It's a $225,700 annual salary. There aren't enough people being paid that on these grants for that to explain the difference, especially when you consider that research salaries are being paid to postdocs and grad students.You're looking around the scientists in your institution and thinking, “That's not where the money is”?Dan: It's not, even if you consider Principal Investigators. If you consider postdocs and grad students, it certainly isn't.Dan: My best hunch is that research projects have become more capital-intensive, and only a certain level of expenditure on equipment can be included in the modified total direct cost base. I don't have smoking gun evidence, it's my intuition.In the paper, there's this fascinating chart where you show the institutions that would get hit hardest by a 15% cap tend to be those that do the most valuable medical research. Explain that on this framework. Is it that doing high-quality medical research is capital-intensive?Pierre: We look at all the private-sector patents that build on NIH research. The more a university stands to lose under the administration policy, the more it has contributed over the past 25 years — in research the private sector found relevant in terms of pharmaceutical patents.This is counterintuitive if your whole model of funding for science is, “Let's cut subsidies for the stuff the private sector doesn't care about — all this big equipment.” When you cut those subsidies, what suffers most is the stuff that the private sector likes.Pierre: To me it makes perfect sense. This is the stuff that the private sector would not be willing to invest in on its own. But that research, having come into being, is now a very valuable input into activities that profit-minded investors find interesting and worth taking a risk on.This is the argument for the government to fund basic research?Pierre: That argument has been made at the macro-level forever, but the bibliometric revolution of the past 15 years allows you to look at this at the nano-level. Recently I've been able to look at the history of Ozempic. The main patent cites zero publicly-funded research, but it cites a bunch of patents, including patents taken up by academics. Those cite the foundational research performed by Joel Habener and his team at Massachusetts General Hospital in the early 1980s that elucidated the role of GLP-1 as a potential target. This grant was first awarded to Habener in 1979, was renewed every four or five years, and finally died in 2008, when he moved on to other things. Those chains are complex, but we can now validate the macro picture at this more granular level.Dan: I do want to add one qualification which also suggests some directions for the future. There are things we still can't see — despite Pierre's zeal. Our projections of the consequence of a 15% rate cap are still pretty coarse. We don't know what research might not take place. We don't know what indirect cost categories are exposed, or how universities would reallocate. All those things are going to be difficult to project without a proper experiment.One thing that I would've loved to have more visibility into is, “What is the structure of indirect costs at universities across the country? What share of paid indirect costs are going to administrative expenses? What direct cost categories are being excluded?” We would need a more transparency into the system to know the answers.Does that information have to be proprietary? It's part of negotiations with the federal government about how much the taxpayer will pay for overhead on these grants. Which piece is so special that it can't be shared?Pierre: You are talking to the wrong people here because we're meta-scientists, so our answer is none of it should be private.Dan: But now you have to ask the university lawyers.What would the case from the universities be? “We can't tell the public what we spend subsidy on”?Pierre: My sense is that there are institutions of academia that strike most lay people as completely bizarre.Hard to explain without context?Pierre: People haven't thought about it. They will find it so bizarre that they will typically jump from the odd aspect to, “That must be corruption.” University administrators are hugely attuned to that. So the natural defensive approach is to shroud it in secrecy. This way we don't see how the sausage is made.Dan: Transparency can be a blessing and a curse. More information supports more considered decision-making. It also opens the door to misrepresentation by critics who have their own agendas. Pierre's right: there are some practices that to the public might look unusual — or might be familiar, but one might say, “How is that useful expense?” Even a simple thing like having an administrator who manages a faculty's calendar might seem excessive. Many people manage their own calendars. At the same time, when you think about how someone's time is best used, given their expertise, and heavy investment in specialized human capital, are emails, calendaring, and note-taking the right things for scientists [to be doing]? Scientists spend a large chunk of their time now administering grants. Does it make sense to outsource that and preserve the scientist's time for more science?When you put forward data that shows some share of federal research funding is going to fund administrative costs, at first glance it might look wasteful, yet it might still be productive. But I would be able to make a more considered judgment on a path forward if I had access to more facts, including what indirect costs look like under the hood.One last question: in a world where you guys have the ear of the Senate, political leadership at the NIH, and maybe the universities, what would you be pushing for on indirect costs?Pierre: I've come to think that this indirect cost rate is a second-best institution: terrible and yet superior to many of the alternatives. My favorite alternative would be one where there would be a flat rate applied to direct costs. That would be the average effective rate currently observed — on the order of 40%.You're swapping out this complicated system to — in the end — reimburse universities the same 40%.Pierre: We know there are fixed costs. Those fixed costs need to be paid. We could have an elaborate bureaucratic apparatus to try to get it exactly right, but it's mission impossible. So why don't we give up on that and set a rate that's unlikely to lead to large errors in under- or over-recovery. I'm not particularly attached to 40%. But the 15% that was contemplated seems absurdly low.Dan: In the work we've done, we do lay out different approaches. The 15% rate wouldn't fully cut out the negotiation process: to receive that, you have to document your overhead costs and demonstrate that they reached that level. In any case, it's simplifying. It forces more cost-sharing and maybe more judicious investments by universities. But it's also so low that it's likely to make a significant amount of high-value, life-improving research economically unattractive.The current system is complicated and burdensome. It might encourage investment in less productive things, particularly because universities can get it paid back through future ICR. At the same time, it provides pretty good incentives to take on expensive, high-value research on behalf of the public.I would land on one of two alternatives. One of those is close to what Pierre said, with fixed rates, but varied by institution types: one for universities, one for medical schools, one for independent research institutions — because we do see some variation in their cost structures. We might set those rates around their historical average effective rates, since those haven't changed for quite a long time. If you set different rates for different categories of institution, the more finely you slice the pie, the closer you end up to the current system. So that's why I said maybe, at a very high level, four categories.The other I could imagine is to shift more of these costs “above the line” — to adapt the system to enable more of these indirect costs to be budgeted as direct costs in grants. This isn't always easy, but presumably some things we currently call indirect costs could be accounted for in a direct cost manner. Foundations do it a bit more than the federal government does, so that could be another path forward.There's no silver bullet. Our goal was to try to bring some understanding to this long-running policy debate over how to fund the indirect cost of research and what appropriate rates should be. It's been a recurring question for several decades and now is in the hot seat again. Hopefully through this work, we've been able to help push that dialogue along. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.statecraft.pub

Dr. Makary Says Dr. Fauci Attempted to Suppress Covid-19 Origin Truth

Play Episode Listen Later Dec 3, 2025 41:01

The Rich Zeoli Show- Hour 4: 6:00pm- Speaking from the Oval Office, President Trump, alongside Transportation Secretary Sean Duffy, announced a repeal of onerous fuel efficiency regulations put in place under the Biden administration. They had been designed to artificially boost electric vehicle manufacturing and sales. Trump described the policy shift as a win for consumers—as the previous efficiency standards led to higher prices on new vehicles. 6:30pm-While speaking with New York Post reporter Miranda Devine, FDA Director and Johns Hopkins surgeon Dr. Marty Makary documented the ways former Director of the National Institute of Allergy and Infectious Diseases Dr. Anthony Fauci was involved in a massive attempt to suppress the truth about Covid-19's origins. 6:40pm- A report from Ernesto Londono of The New York Times documents rampant fraud plaguing Minnesota—dozens of people have been charged with stealing more than $1 billion in taxpayer money from programs meant to feed hungry children and provide therapy for autistic children. Critics of Governor Tim Walz say his administration allowed the fraud to persist “partly because state officials were fearful of alienating the Somali community” who were largely responsible for the scams.

Trump Terminates Disastrous Biden Fuel Efficiency Regulations

study national caring cannabis associate professor cbd psychiatry johannes realm roc johns hopkins behavioral sciences chri research initiative cannabis health

Play Episode Listen Later Dec 3, 2025 183:02

The Rich Zeoli Show- Full Show (12/03/2025): 3:05pm- A report from Ernesto Londono of The New York Times documents rampant fraud plaguing Minnesota—dozens of people have been charged with stealing more than $1 billion in taxpayer money from programs meant to feed hungry children and provide therapy for autistic children. Critics of Governor Tim Walz say his administration allowed the fraud to persist “partly because state officials were fearful of alienating the Somali community” who were largely responsible for the scams. 3:10pm- While speaking with the press on Tuesday, President Donald Trump called for a reduction of migrants from third world countries who are openly unwilling to assimilate to American culture. 3:20pm- Philadelphia Highway Patrol Officer Andy Chan has died six years after he was struck by a vehicle while on duty. Rich notes that Officer Chan was a friend of the show. Next Friday the show will be broadcasting from the 6th Annual Andy Chan Holiday Block Party. 3:30pm- Speaking from the Oval Office, President Trump, alongside Transportation Secretary Sean Duffy, announced a repeal of onerous fuel efficiency regulations put in place under the Biden administration. They had been designed to artificially boost electric vehicle manufacturing and sales. 4:05pm- Speaking from the Oval Office, President Trump, alongside Transportation Secretary Sean Duffy, announced a repeal of onerous fuel efficiency regulations put in place under the Biden administration. They had been designed to artificially boost electric vehicle manufacturing and sales. Trump described the policy shift as a win for consumers—as the previous efficiency standards led to higher prices on new vehicles. 4:40pm- Carrie Severino—President of the Judicial Crisis Network (JCN) & Co-Author of the book, “Justice on Trial: The Kavanaugh Confirmation and the Future of the Supreme Court.”—joins The Rich Zeoli Show. On Tuesday, the U.S. Supreme Court heard oral argument in First Choice Women's Resource Centers v. Platkin. The case asks whether a federal court can hear First Choice's First Amendment challenge to a New Jersey investigatory subpoena when no state court has yet ordered the group to comply. While being questioned by Justice Clarence Thomas, NJ Attorney General Sundeep Iyer conceded that NJ hasn't received any public complaints to justify its subpoena against the pro-life health center. 5:05pm- A Washington Post report states that Department of War Secretary Pete Hegseth authorized a series of deadly strikes on a drug trafficking boat in the Caribbean, ordering military officials to “kill everybody.” The directive, according to the report, led to a second strike killing several crew members that survived the initial assault on the vessel. The New York Times, as well as the White House, dispute that Hegseth explicitly authorized the second strike or ordered to eliminate survivors. The NYT also reports that the “U.S. military intercepted radio communications from one of the survivors to what [officials] said were narco-traffickers.” 5:30pm- Following the Eagles loss to the Bears on Friday, Offensive Coordinator Kevin Patullo had his house egged. Does Justin have an alibi? Plus, a drunk racoon ransacked a convenience store! And “Be Nice to Matt Week” continues…sort of… 6:00pm- Speaking from the Oval Office, President Trump, alongside Transportation Secretary Sean Duffy, announced a repeal of onerous fuel efficiency regulations put in place under the Biden administration. They had been designed to artificially boost electric vehicle manufacturing and sales. Trump described the policy shift as a win for consumers—as the previous efficiency standards led to higher prices on new vehicles. 6:30pm-While speaking with New York Post reporter Miranda Devine, FDA Director and Johns Hopkins surgeon Dr. Marty Makary documented the ways former Director of the National Institute of Allergy and Infectious Diseases Dr. Anthony Fauci was involved in a ma ...

The National Cannabis Study with Ryan Vandrey, PhD & Johannes Thrul, PhD

CannMed Coffee Talk

Play Episode Listen Later Dec 3, 2025

Dr. Ryan Vandrey is a professor of Psychiatry and Behavioral Sciences at Johns Hopkins. Dr. Johannes Thrul is an Associate Professor at Johns Hopkins. They both work for the Cannabis Health & Research Initiative, which is a collaboration between two organizations with years of experience in medicinal cannabis research: Johns Hopkins University and Realm of Caring. Simply put, CHRI is a platform of data collection and dissemination focused on the health outcomes of medicinal cannabis at the patient level, and they have created a number of valuable resources to help cannabis medicine researchers, including: A data repository that contains de-identified data collected through CHRI Research Library that contains more than 3000 published scientific articles related to the health effects of cannabis A set of validated questionnares that clinicians can use when speaking to patients about cannabis – and more The CHRI is also currently recruiting participants for their National Cannabis Study, which is a collection of firsthand experiences with medicinal cannabis among individuals with various health conditions. Specifically, they are looking for participants who plan to use cannabis but have not yet started cannabis use. So if that's you or someone you know, we highly suggest you consider participating in the study because the research has the potential to impact best practices in healthcare and the cannabis industry. During our conversation, Ryan and Johannes shared more details about the CHRI and the National Cannabis Study, and I think you will agree that their mission aligns perfectly with the CannMed Community. Thanks to This Episode’s Sponsor: Realm of Caring Founded in 2013, Realm of Caring (RoC) serves anyone in need of more information about cannabinoid therapies. Through revolutionary CBD and Cannabis research, innovative education, and life-changing grants, RoC seeks to facilitate and encourage the mainstream acceptance of transformative, plant powered therapies to benefit individuals and families and serve healthcare providers as well as the hemp and cannabis industries. Learn more at realmofcaring.org Additional Resources Cannabis Health Research Initiative website – cannabisandhealth.org

EPI 228: Andrew Koutnik, PhD - Why Improving Your Metabolic Health With Evidence Based Solutions Is The Most Important Thing You Can Do. Plus How To Manage & Avoid Getting Both Type 1 & Type 2 Diabetes.

Peak Performance Life Podcast

Play Episode Listen Later Dec 2, 2025 72:08

Show notes: (0:00) Intro (1:17) Dr. Andrew Koutnik's background & obesity struggles (5:00) Lifestyle's surprising role in autoimmune disease risk (7:47) The rise of metabolic dysfunction in kids and adults (13:17) Key health markers to watch (18:55) Can a ketogenic diet reverse metabolic dysfunction? (30:04) 10-year ketogenic case study results (42:30) Advice for the "average" person looking to feel better (51:10) How to reduce carbs without giving up your favorite foods (57:50) Why short-term cravings can cost your long-term health (1:01:10) Why current diabetes guidelines may not reflect the latest science (1:08:36) Final thoughts and where to find Dr. Koutnik's resources (1:09:21) Outro Who is Dr. Andrew Koutnik? Dr. Andrew Koutnik, PhD, is a biomedical researcher with expertise in metabolism, nutrition, and disease. He earned his PhD at Florida State University in Biomedical Sciences, studying how metabolism-based therapies like the ketogenic diet impact health and performance. He has worked with leading institutions, including NASA, Harvard, Johns Hopkins, and the Department of Defense, translating cutting-edge research into practical tools for improving metabolic health, managing chronic disease, and optimizing physical and cognitive performance. As someone living with type 1 diabetes, Dr. Koutnik combines deep scientific knowledge with personal experience. He has published extensively on topics such as metabolic therapy, insulin resistance, and the ketogenic diet's role in chronic disease. He is also an advocate for evidence-based lifestyle interventions and works directly with elite athletes, military professionals, and everyday individuals to help them thrive through science-backed nutrition and lifestyle strategies. Connect with Dr. Koutnik: Website: http://andrewkoutnik.com IG: https://www.instagram.com/andrewkoutnikphd/ YT: https://www.youtube.com/@AKoutnik Links and Resources: Peak Performance Life Peak Performance on Facebook Peak Performance on Instagram

advice phd lifestyle harvard nasa defense improving manage yt johns hopkins florida state university evidence based type1 type 2 diabetes metabolic health biomedical sciences

Rachael Wonderlin: How She Built a Thriving Consulting Business, Broke Out of Her Niche, and Learned to Trust Her Gut

Everyday Bad Ass Women Leaders

Play Episode Listen Later Dec 2, 2025 46:22

Send us a textRachael Wonderlin built a national dementia consulting firm from a Tumblr blog, three Johns Hopkins books, and a decade of hands-on work inside senior living communities. But the real story is what she learned along the way about boundaries, burnout, and trusting her intuition long before the data caught up.In this conversation, Rachael shares the full arc of building Dementia By Day from a one-woman hustle into a recurring revenue business that now operates like fractional operations for senior living companies. She talks about the early years when she said yes to everything, the moment she realized she needed a different model, and the systems she created to stop chasing one-off gigs.She also opens up about being pigeonholed as “just” a dementia expert, the tone deaf advice she received while pitching her fourth book, and the unregulated coaching industry that inspired her business memoir, I Can't Hustle Any Harder Than This.If you're building a business, struggling with boundaries, or fighting your way out of a niche that people keep trying to trap you in, this episode gives you the clarity you need to move forward with confidence.In this episode, Rachael shares: • How she turned a blog into a national consulting firm • The moment she learned to stop saying yes to everything • How she built recurring revenue and stopped chasing the next gig • The difference between coaching and consulting, and why clarity matters • Why the coaching industry can harm entrepreneurs who are just getting started • The story of the agent who told her to write a “funny dementia book” • How she is repositioning herself as a business leader, not only a dementia expert • The evolution of dementia care and why public awareness has changed • Why she refuses to use AI to create content • How her viral web comics reached hundreds of thousands of people • What hiring mistakes taught her about leadership and trust • The one lesson she wants every business owner to learn: if your gut says no, believe itKey quote: “If your gut reaction is ‘oh hell no,' that is the answer. Stop arguing with yourself. Say no and move on.”CONTACT INFORMATIONRachael Wonderlin Founder and CEO, Dementia By Day Website: dementiabyday.com LinkedIn: linkedin.com/in/rachaelwonderlin Instagram: @dementiabyday and @cant_hustleanyharder Substack: Can't Hustle Any Harder--- Subscribe and ReviewIf you loved this episode, drop us a review, share it with a badass woman in your life, and subscribe to Badass Women in Business wherever you get your podcasts. Stay badass. Stay bold. Build it your way. Keep up with more content from Aggie and Cristy here: Facebook: Empowered Women Leaders Instagram: @badass_women_in_business LinkedIn: ProveHer - Badass Women in Business Website: Badasswomeninbusinesspodcast.com Athena: athenaac.com

ceo trust ai built thriving broke niche tumblr johns hopkins consulting business

Ep. #152: What Breaks When Coaches, Athletes, and Parents Stay Silent? With Janine Tucker and Tracey Currey

The GenZ Show with James McLamb

Play Episode Listen Later Dec 2, 2025 40:48

What Breaks When Coaches, Athletes, and Parents Stay Silent? With Janine Tucker and Tracey Currey

parents breaks coaches athletes johns hopkins stay silent currey

WaPo Report: Was Caribbean Boat Strike Lawful?

news food boats washington post caribbean strike lyme new york post johns hopkins federal bureau wapo lawful dan bongino marty makary investigation fbi miranda devine

Play Episode Listen Later Dec 1, 2025 39:10

The Rich Zeoli Show- Hour 4: 6:00pm- A Washington Post report states that Department of War Secretary Pete Hegseth authorized a series of deadly strikes on a drug trafficking boat in the Caribbean, ordering military officials to “kill everybody.” The directive, according to the report, led to a second strike killing several crew members that survived the initial assault on the vessel. 6:20pm- Food and Drug Administration (FDA) Commissioner, and Johns Hopkins surgeon, Dr. Marty Makary weighed in on a theory that Lyme disease may have originated from a bioweapons laboratory. 6:40pm- In her latest editorial for The New York Post, Miranda Devine writes that a “damning report” labels the Federal Bureau of Investigation (FBI) as a “rudderless ship” and “all f*cked up” under the leadership of Director Kash Patel and Deputy Director Dan Bongino. The report alleges that Bongino has an “unfortunate obsession with social media.”

Massive Fraud in Minnesota Went Ignored By Tim Walz

Play Episode Listen Later Dec 1, 2025 180:07

The Rich Zeoli Show- Full Episode (12/01/2025): 3:05pm- The man allegedly responsible for shooting two National Guard members had been granted asylum from Afghanistan. While on Meet the Press, Department of Homeland Security Secretary Krisit Noem said initial investigations suggest the man became radicalized while in the United States. 3:10pm- In her latest editorial for The New York Post, Miranda Devine writes that a “damning report” labels the Federal Bureau of Investigation (FBI) as a “rudderless ship” and “all f*cked up” under the leadership of Director Kash Patel and Deputy Director Dan Bongino. The report alleges that Bongino has an “unfortunate obsession with social media.” 3:30pm- A report from Ernesto Londono of The New York Times documents rampant fraud plaguing Minnesota—dozens of people have been charged with stealing more than $1 billion in taxpayer money from programs meant to feed hungry children and provide therapy for autistic children. Critics of Governor Tim Walz say his administration allowed the fraud to persist “partly because state officials were fearful of alienating the Somali community” who were largely responsible for the scams. 3:50pm- It's finally here! “Be Nice to Matt DeSantis Week” kicks off. Earlier this year, Linda Kerns—Attorney & Pennsylvania Election Integrity Counsel for the Republican National Committee and Donald Trump—donated money to the Travis Manion Foundation during 1210 WPHT's fundraiser in exchange for Rich guaranteeing he would be nice to Matt for one full week before the end of the year. 4:05pm- A report from Ernesto Londono of The New York Times documents rampant fraud plaguing Minnesota—dozens of people have been charged with stealing more than $1 billion in taxpayer money from programs meant to feed hungry children and provide therapy for autistic children. Critics of Governor Tim Walz say his administration allowed the fraud to persist “partly because state officials were fearful of alienating the Somali community” who were largely responsible for the scams. 4:15pm- Is even Europe getting sick of far-left taxation policies? On Sunday, Switzerland rejected a referendum that would have placed a 50% inheritance tax on assets above 50 million Swiss francs, or about $62 million. 4:40pm- TV recommendations: Death by Lightning on Netflix—which is based on Candece Millard's book on the assassination of President James Garfield. 5:05pm- The man allegedly responsible for shooting two National Guard members had been granted asylum from Afghanistan. While on Meet the Press, Department of Homeland Security Secretary Krisit Noem said initial investigations suggest the man became radicalized while in the United States. National Guard member Sarah Beckstorm, sadly, died from her wounds. Meanwhile, Guardsman Andrew Wolfe remains in critical condition. West Virginia Gov. Patrick Morrisey said Wolfe was responsive on Monday. 5:25pm- Last month, while speaking from the House floor, Rep. Jasmine Crockett (D-TX) accused several Republicans including EPA Administrator Lee Zeldin of taking campaign donations from Jeffrey Epstein. However, her claim was horribly misleading. The donations were from a Dr. Jeffrey Epstein—a different Jeffery Epstein, with no relation to the predator. Astoundingly, Crockett recently doubled down on her outlandish claims during a segment on MS Now. 5:40pm- Linda Kerns calls in to outline the rules for “Be Nice to Matt Week”—so far, Rich has violated every instruction. 6:00pm- A Washington Post report states that Department of War Secretary Pete Hegseth authorized a series of deadly strikes on a drug trafficking boat in the Caribbean, ordering military officials to “kill everybody.” The directive, according to the report, led to a second strike killing several crew members that survived the initial assault on the vessel. 6:20pm- Food and Drug Administration (FDA) Commissioner, and Johns Hopkins surgeon, Dr. Marty Makary weighed in on a theory that ...

Pathology with Dr. Priya | Death by a Thousand Cuts: The Cruel Science of Slow Deaths

Play Episode Listen Later Dec 1, 2025 29:39 Transcription Available

Content Warning: This episode discusses eating disorders, starvation, and medical neglect. Listener discretion is advised. This week on Pathology with Dr. Priya, a Zone 7 series, Sheryl McCollum and Dr. Priya Banerjee look at some of the most painful and complex ways a body can fail, from starvation and radiation exposure to delayed deaths that can take years to claim a life. Dr. Priya Breaks down the science of how the body deteriorates during starvation, explains why children in famine zones appear bloated, and discusses both abuse and eating disorder cases that show the psychological and biological devastation of prolonged deprivation. They also explore radiation-linked illnesses, the hidden risks of environmental exposure, and what happens when a wound or poisoning leads to death years later. Through every case, Dr. Priya explains the forensic details behind a “slow death” and why, for the body, nothing about it is slow. Highlights • (0:00) Sheryl welcome listeners and introduces the topic: slow deaths • (3:00) Why Thanksgiving reminds Sheryl of slow deaths and what starvation really is • (4:00) Dr. Priya explains how starvation breaks the body down from within, and how it can stem from both illness and abuse • (12:45) Dr. Priya describes why starving children often appear bloated and the biology behind kwashiorkor• (16:15) Radiation exposure: how time, dose, and distance determine long-term damage • (20:45) Delayed deaths, paralysis, and the challenge of proving causation • (26:15) "Death by a thousand cuts": how blood loss from minor wounds can still be lethal, and how even old wounds can become deadly decades later • (29:00) Closing thoughts: Sheryl and Dr. Priya reflect on the cruelty of slow deaths About the Hosts Dr. Priya Banerjee is a board-certified forensic pathologist with extensive experience in death investigation, clinical forensics, and courtroom testimony. A graduate of Johns Hopkins, she served for over a decade as Rhode Island’s state medical examiner and now runs a private forensic pathology practice. Her work includes military deaths, and high-profile investigations. Dr. Priya has also been featured as a forensic expert on platforms such as CrimeOnline and Crime Stories with Nancy Grace. She is a dedicated educator, animal lover, and proud mom. Website: anchorforensicpathology.com Twitter/X: @Autopsy_MD Sheryl “Mac” McCollum is an active crime scene investigator for a Metro Atlanta Police Department and the director of the Cold Case Investigative Research Institute, which partners with colleges and universities nationwide. With more than 4 decades of experience, she has worked on thousands of cold cases using her investigative system, The Last 24/361, which integrates evidence, media, and advanced forensic testing. Her work on high-profile cases, including The Boston Strangler, Natalie Holloway, Tupac Shakur and the Moore’s Ford Bridge lynching, led to her Emmy Award for CSI: Atlanta and induction into the National Law Enforcement Hall of Fame in 2023. Email: coldcase2004@gmail.com Twitter/X: @ColdCaseTips Facebook: @sheryl.mccollum Instagram: @officialzone7podcast Preorder Sheryl’s upcoming book, Swans Don’t Swim in a Sewer: Lessons in Life, Justice, and Joy from a Forensic Scientist, releasing May 2026 from Simon and Schuster. https://www.simonandschuster.com/books/Swans-Dont-Swim-in-a-Sewer/Sheryl-Mac-McCollum/9798895652824 If this episode gave you a new understanding of the science behind slow deaths, share it with a friend and leave a review. Your support helps others discover the science, the stories, and the heart behind Pathology with Dr. Priya | A Zone 7 Series.See omnystudio.com/listener for privacy information.

How to Age-Proof Your Brain and Stay Sharp for Life - with Dr. Majid Fotuhi

The Daria Hamrah Podcast

Play Episode Listen Later Dec 1, 2025 108:50 Transcription Available

Send us a textMost people think memory loss is a downhill slide you can't stop. We don't. In this conversation with neurologist and neuroscientist Dr. Majid Fotuhi, we map out a twelve‑week blueprint that measurably improves memory, focus, and even grows hippocampal volume by targeting the real drivers of decline: poor sleep, chronic stress, insulin resistance, hearing loss, inactivity, and hidden medical issues.Dr. Majid Fotuhi is a pioneering neurologist, neuroscientist, and professor with more than thirty-five years of experience in brain health, memory, neuroplasticity, and the prevention of Alzheimer's disease. His work bridges research, clinical innovation, and public education.He earned his PhD in neuroscience from Johns Hopkins University, completed medical training at Harvard Medical School, and returned to Johns Hopkins for his neurology residency. He currently serves as an adjunct professor at Johns Hopkins University.An author and communicator, Dr. Fotuhi has written several books and is known for making complex science accessible. His excellence in teaching earned him the American Academy of Neurology's prestigious award. His research has appeared in peer-reviewed journals, been presented at major conferences, and cited widely by scientists worldwide.Dr. Fotuhi has created a twelve-week program that has helped thousands of patients with memory loss, brain fog, concussion, mild cognitive impairment, and early Alzheimer's disease. His expertise has been featured by CNN, NBC News, the Today Show, ABC News, The New York Times, The Washington Post, and The Times (London).We start by clarifying what mild cognitive impairment is, how it differs from dementia, and why so many cases are preventable. Dr. Fotuhi explains the “type 3 diabetes” model—how decades of sugar spikes and inflammation erode the blood‑brain barrier and starve neurons of a stable environment. Then we get practical. You'll hear how a personalized “brain portfolio” guides treatment: VO2 max testing to shape exercise, sleep studies and CPAP when needed, targeted brain training that matches deficits, and labs for vitamin D, B12, and omega‑3 status. The results? Early wins in two to three weeks, statistically significant gains at six and twelve, and habits that stick.We don't stop at diet and steps. Oral health impacts cognition by limiting whole foods and increasing inflammation; chewing itself engages neural circuits. Hearing loss quietly accelerates decline—hearing aids can move people from mild impairment back to normal. Add a simple, sustainable food approach—ditch ultra‑processed foods, eat vegetables, legumes, fruits, quality proteins, and healthy fats—and consider targeted supplementation with DHA/EPA omega‑3s and corrected D and B12 levels. Along the way, we address why amyloid hogged the spotlight, and point to powerful data: the Lancet's estimate that 45% of dementia cases are preventable and the American Heart Association's claim that 80% of strokes can be avoided.If you want a sharper brain by summer, this is your starting line. Subscribe, share this with someone you love, and leave a review telling us the one habit you'll change this week. Your future brain will thank you.Links:Majid Fotuhi, MD, PhD: https://drfotuhi.com/https://krieger.jhu.edu/mbi/directory/majid-fotuhi/https://neurogrow.com/about-us/dr-majid-fotuhi-md-phd/https://psychology.columbian.gwu.edu/majid-fotuhiTweet me @realdrhamrahIG @drhamrah

TWiV 1274: Clinical update with Dr. Daniel Griffin

silicon valley johns hopkins live forever dave asprey peter attia attia i went wellness summit

Play Episode Listen Later Nov 29, 2025 58:25

In his weekly clinical update, Dr. Griffin and Vincent Racaniello wish everyone a Happy Thanksgiving and then decry appointment of the Louisiana State surgeon general as deputy chief of the CDC, the 3 children's deaths during this fall's pertussis outbreak, the Marburg virus outbreak in Ethiopia, results of the phase 1 safety trial for the novel poliovirus vaccines nOPV1 and nOPV3, and the first human death from H5N5 influenza virus infection in the US this fall, before Dr. Griffin deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, effectiveness of the cell or egg based flu or the mRNA vaccines, immunogenicity and efficacy of updated COVID-19 vaccines, where to find PEMGARDA, how to access and pay for Paxlovid, long COVID treatment center, where to go for answers to your long COVID questions, immune and cognitive dysfunction during long COVID and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Anti-science Movement: Deputy director of CDC (X:Louisiana Office of the Surgeon General) CDC's new deputy director is vocal critic of vaccines, advocated for ivermectin (CIDRAP) Whooping cough cases on the rise in Texas (FOX4: KDFW) Third infant in Kentucky dies of whooping cough as national cases stay high for second year in a row (CIDRAP) More than 25,000 whooping cough cases reported this year as Kentucky records 3rd infant death (ABC News) Vaccination Coverage and Exemptions among Kindergartners (CDC: SchoolVaxView) Effects of human papillomavirus (HPV) vaccination programmes on community rates of HPV‐related disease and harms from vaccination (Cochrane Library) Marburg Outbreak in Ethiopia: Current Situation (CDC: Marburg Virus Disease) Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trial (LANCET: Infectious Diseases) Washington state resident believed to be the first to die from a rare strain of bird flu (AP News) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) Superior Effectiveness and Estimated Public Health Impact of Cell- Versus Egg-Based Influenza Vaccines in Children and Adults During the US 2023–2024 Season (Infectious Diseases and Therapy) Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine(NEJM) ACIP Recommendations Summary (CDC: Influenza) Types of Influenza Viruses (CDC: Influenza (flu)) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season (FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Estimating Risk of Guillain-Barré Syndrome in US Medicare-Enrolled Older Adults Following Medically Attended Respiratory Syncytial Virus Disease (CID) FDA Requires Guillain-Barré Syndrome (GBS) Warning in the Prescribing Information for RSV Vaccines Abrysvo and Arexvy: FDA Safety Communication (FDA) Brag Sets Off a Chain Reaction — Dr. Oz Takes the Bait, But Fumbles the Math, and Starts Unraveling Mid-Interview (Atlanta BlackStar) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Effectiveness of the BNT162b2 and mRNA-1273 JN.1-adapted vaccines against COVID-19-associated hospitalisation and death: a Danish, nationwide, register-based, cohort study (LANCET: Infectious Diseases) Immunogenicity of JN.1- and KP.2-Encoding mRNA COVID-19 Vaccines Against JN.1 Subvariants in Adult Participants (OFID) SARS-CoV-2 vaccination and myositis in Norway and Sweden (Rheumatology) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Digitally Assessed Long COVID Symptomatology Is Associated With Lymphocyte Mitochondrial Dysfunction and Altered Immune Potential (OFID) Evaluation of Interventions for Cognitive Symptoms in Long COVID (JAMA Neurology) Reaching out to US house representative Letters read on TWiV 1274 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

285: Can Peter Attia Live Forever?

Conspirituality

Play Episode Listen Later Nov 27, 2025 71:18

In the wildly popular biohacking and longevity space, Peter Attia is often cited as one of the leading luminaries. His straightforward, science-backed approach seems to cut through the noise in a space dominated by fit bros and wellness grifters who always seem to have a product to sell. But the man who dropped out of residency at Johns Hopkins to found a private clinic focused on longevity has his share of critics, who are a bit suspicious about his self-experimentations—and the millions he makes counseling Silicon Valley insiders about experimental medicine. This week we take a look at longevity broadly and Attia specifically. Derek kicks off the episode with a recap of his time at Eudemonia Summit, where, among other things, he got to debate another leading biohacker, Dave Asprey, about seed oils. As it turns out, longevity was the top buzzword there as well. I Went to Eudemonia – a Wellness Summit with the Industry's Top Thought Leaders – Here's What It Was Like Outlive: A Critical Review A Review of OUTLIVE Critiquing Peter Attia Andrew Huberman and Peter Attia: Self-enhancement, supplements & doughnuts? Learn more about your ad choices. Visit megaphone.fm/adchoices

Series 3, Episode 19: Why leadership development is failing us, with Professor Moran Anisman-Razin, University of Limerick

Brain for Business

Play Episode Listen Later Nov 26, 2025 29:14

According to Forbes magazine, in 2020 alone global spend on corporate training programmes, often focused on leadership development, exceeded $350 billion. Yet how effective, if at all, are these programmes? And are they perhaps just a massive waste of time and money? To dig deep into the question of why leadership development might be failing us I am delighted to be joined on the podcast by Professor Moran Anisman-Razin.About our guest…Dr. Moran Anisman-Razin, is an Associate Professor of Work and Organizational Psychology in the Department of Work and Employment Studies at the Kemmy Business School, University of Limerick. She is also a Visiting Research Scholar at the Behavioral Science and Policy Center, Social Science Research Institute at Duke University, USA and Faculty Affiliate at the Center for Innovative Leadership, Carey Business School, Johns Hopkins university. Through her work, Moran explores questions of leadership in organizations and is particularly interested in examining leaders' perspectives and identities as shaping behavior, leader development, and exploring ways to make leadership development programs more evidence-based and rigorous.The MIT Sloan Management Review article discussed in the interview - Leadership Development Is Failing Us. Here's How to Fix It - is available here: https://sloanreview.mit.edu/article/leadership-development-is-failing-us-heres-how-to-fix-it/A key article also referenced in the interview - Uncomfortable but Developmental: How Mindfulness Moderates the Impact of Negative Emotions on Learning - https://journals.aom.org/doi/abs/10.5465/amle.2023.0434 Hosted on Acast. See acast.com/privacy for more information.

united states university learning work professor impact forbes associate professor acast failing uncomfortable duke university leadership development johns hopkins series 3 moran behavioral sciences limerick fix it negative emotions organizational psychology policy center mit sloan management review innovative leadership faculty affiliate employment studies carey business school visiting research scholar kemmy business school

Headline: "P Diddy Embroiled in Federal Raid and Controversy: Secrets Exposed in Upcoming Netflix Docuseries"

Sean Combs - Diddy on the run

Play Episode Listen Later Nov 26, 2025 2:36 Transcription Available

Sean Combs, known as Puffy and P Diddy, has dominated headlines recently following a series of legal and personal controversies that have captivated the public. Earlier this year, federal agents raided his luxury homes in California and Miami. The shocking scene included footage of his sons Justin and King, both handcuffed and detained as Homeland Security executed a search warrant at his $40 million Los Angeles mansion. News helicopters and drone cameras captured the dramatic moment, sending the internet into a frenzy as speculations about the nature of the investigation swirled. According to STRIPE at Johns Hopkins, authorities employed what some witnesses claimed was “excessive” force during the operation. That footage showed the rapper's sons and an unknown companion standing handcuffed outside the lavish Holmby Hills residence, with their mother, Misa Hylton, quickly posting a video online expressing concern for their wellbeing.While Sean Combs has strongly denied any allegations related to these raids, discussions have intensified about possible federal investigations, especially surrounding whispers of a sex trafficking probe. Reports from Pirdop.com highlight how these unconfirmed rumors have led to widespread speculation in both the music industry and online communities about whether the hip hop mogul is actively wanted by federal authorities.Amidst this turbulence, Combs' business ventures remain under scrutiny, but insiders from RiteMate point out that his entrepreneurial reach continues. He maintains stakes in Ciroc vodka and Revolt TV, and his reputation for both fashion and music innovation still draws public attention despite recent controversies.Adding to the media storm, Netflix is set to release a new documentary, “Sean Combs: The Reckoning,” on December 2, 2025. Produced in association with Fifty Cent, this four-part exposé promises to take listeners behind the scenes of Combs' complicated life—shedding light on both his achievements and the darker chapters that have surfaced. With Hulu, Peacock, and other competitors missing out, Netflix's global premiere is generating significant buzz in entertainment news.Thanks for tuning in, and make sure to come back next week for more updates. This has been a Quiet Please production. For more, check out Quiet Please Dot A I.Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

Episode 545: Using the Human Eye to Detect Early Alzheimer's and Infection-Induced Brain Changes – Dr. Sean Miller (Yale)

Tick Boot Camp

Play Episode Listen Later Nov 25, 2025 11:19

Overview This special episode of the Tick Boot Camp Podcast was recorded live at the 2nd Annual Alzheimer's Pathobiome Initiative (AlzPI) and PCOM Symposium in collaboration with Pathobiome Perspectives. Hosted by Ali Moresco in partnership with Nikki Schultek, Executive Director of AlzPI, the conversation brings the Tick Boot Camp mission of exploring infection-associated chronic illness (IACI)—including Lyme disease and other tick-borne infections—to the global Alzheimer's and neuroimmunology research community. Tick Boot Camp co-founders Matt Sabatello and Rich Johannesen partnered with Ali and Nikki to highlight leading scientists connecting infection, immune dysfunction, and cognitive decline. This episode features Dr. Sean Miller, a neuroscientist and co-investigator in the Logan Lab with a primary appointment at Yale School of Medicine, who is developing ways to non-invasively detect Alzheimer's-like pathology through the eye. Guest Sean Miller, PhD Co-Investigator, Logan Lab / Yale School of Medicine Dr. Sean Miller completed pre-doctoral work at Harvard Medical School, earned his PhD from Johns Hopkins University, and completed post-doctoral training at Stanford University. His research focuses on neurodegeneration, neuroglia, and early diagnostic strategies for Alzheimer's and related diseases. At the AlzPI & PCOM Symposium, Dr. Miller presented evidence showing that SARS-CoV-2 (COVID-19) infection can accelerate Alzheimer's-like pathology and that these changes can be detected non-invasively through retinal imaging. His findings suggest that amyloid-beta, a protein long associated with Alzheimer's disease, may also serve as part of the brain's antimicrobial defense system—trapping pathogens like a mesh or biofilm, but leading to damaging plaque buildup when overproduced. Key Discussion Points Dr. Miller describes how the COVID-19 virus can act as an infectious trigger for neuroinflammation and amyloid buildup, how the eye provides a unique window into the brain, and why early detection is essential to preventing neuron death. He shares how his lab's AI-enhanced retinal imaging research at Yale Eye Center is identifying amyloid and tau deposits in patients with long COVID-related brain fog—opening the possibility of routine eye exams doubling as early Alzheimer's screening tools. He explains potential therapeutic strategies, such as limiting amyloid production during infection flare-ups and enhancing clearance mechanisms afterward to reduce chronic plaque formation. The conversation also explores his scientific journey—from designing Alzheimer's drugs at Harvard and Johns Hopkins to realizing the need for early disease detection during his postdoc at Stanford—and how the pandemic inspired his focus on infection-induced neurodegeneration. “We believe neurons are exposed to pathogens in the central nervous system and respond by secreting amyloid-beta to trap them. Excessive plaque buildup from repeated or severe infections may be what drives long-term neurodegeneration.” — Dr. Sean Miller Why It Matters Dr. Miller's research connects infectious disease, ophthalmology, and neurology, providing a revolutionary new method to screen for early Alzheimer's-like changes non-invasively through the human eye. His work suggests that infections like COVID-19 may trigger the same protective—but damaging—immune responses implicated in chronic conditions such as Alzheimer's disease and infection-associated cognitive decline. About the Event The interview took place at the 2nd Annual Alzheimer's Pathobiome Initiative (AlzPI) and Philadelphia College of Osteopathic Medicine (PCOM) Symposium, held on October 3, 2025, at Ohio University in Dublin, Ohio. The event brought together more than 20 global researchers exploring how microbes, the microbiome, and the immune response contribute to Alzheimer's, dementia, PANS/PANDAS, and infection-associated chronic illnesses (IACI). Tick Boot Camp partnered with Ali Moresco and Nikki Schultek to share the voices of researchers advancing the field of infection-associated chronic illness. This episode is part of a multi-part Tick Boot Camp series highlighting how pathobiome and microbiome science are transforming the understanding of Lyme disease, infection, and neurodegeneration. Learn More Learn more about the Alzheimer's Pathobiome Initiative (AlzPI) Listen to Tick Boot Camp Podcast episodes, including Episode 406: Pathobiome – An Interview with Nikki Schultek and Episode 101: The Young Gun – An Interview with Alex (Ali) Moresco discussed in this interview.

Pathology with Dr. Priya | Recreating a Cold Case Scene to Test the Story

The Heart of Healthcare with Halle Tecco

Play Episode Listen Later Nov 24, 2025 27:52 Transcription Available

A photograph can provide documentation but can’t tell the whole story. This week on Pathology with Dr. Priya, a Zone 7 series, Dr. Priya Banerjee joins Sheryl McCollum to share why revisiting a cold-case scene, sometimes decades later, can completely shift an investigation. When she traveled for hours to inspect an identical car tied to a cold case, she discovered details impossible to see on paper. They talk about how vehicles can become part of the forensic story, why the setting itself matters, and how today’s technology can clarify what investigators once assumed. From seat position to power locks, their conversation highlights what’s lost when professionals rely only on reports and what’s gained when they return to the scene. Highlights • (0:00) Sheryl welcome listeners and introduces the topic: why visiting a scene is essential in cold-case investigations • (1:00) Dr. Priya describers visiting a cold-case scene and inspecting an identical car for accuracy • (2:15) The car as a crime scene: how transport vehicles create multiple evidence locations • (3:30) How changing car technology, from manual locks to sensors, alters forensic interpretation • (5:00) What revisitng a scene reveals that photos and reports cannot • (10:00) Revisiting old neighborhoods and the effects of time, urban change, and memory on case context • (12:00) Dr. Priya’s methodical process for documenting and photographing scene and how that strengthens her courtroom testimony • (13:15) Returning submerged and long-missing vehicles and bringing families long-awaited closure • (14:30) Dr. Priya on method, teamwork, and why working cold cases feels like giving back • (20:45) Revisiting old files with fresh eyes: how old photos, modern technology, and tools like Othram and NamUs can finally move cold cases forward About the Hosts Dr. Priya Banerjee is a board-certified forensic pathologist with extensive experience in death investigation, clinical forensics, and courtroom testimony. A graduate of Johns Hopkins, she served for over a decade as Rhode Island’s state medical examiner and now runs a private forensic pathology practice. Her work includes military deaths, and high-profile investigations. Dr. Priya has also been featured as a forensic expert on platforms such as CrimeOnline and Crime Stories with Nancy Grace. She is a dedicated educator, animal lover, and proud mom. Website: anchorforensicpathology.com Twitter/X: @Autopsy_MD Sheryl McCollum is an Emmy Award–winning CSI, a writer for CrimeOnline, and the Forensic and Crime Scene Expert for Crime Stories with Nancy Grace. She works as a CSI for a metro Atlanta Police Department and is the co- author of the textbook Cold Case: Pathways to Justice. Sheryl is also the founder and director of the Cold Case Investigative Research Institute (CCIRI), a nationally recognized nonprofit that brings together universities, law enforcement, and experts to help solve unsolved homicides, missing persons cases, and kidnappings. Email: coldcase2004@gmail.com Twitter/X: @ColdCaseTips Facebook: @sheryl.mccollum Instagram: @officialzone7podcast If this episode gave you a new understanding of cold case investigations, share it with a friend and leave a review. Your support helps others discover the science, the stories, and the heart behind Pathology with Dr. Priya | A Zone 7 Series. See omnystudio.com/listener for privacy information.

Fixing Rural Healthcare Before It Collapses | Homeward Co-founder & CEO Dr. Jennifer Schneider

Play Episode Listen Later Nov 24, 2025 34:55

As millions of Americans hit the road to visit family for Thanksgiving, many will pass through, or return to, rural communities. Nearly 60 million Americans live in these areas, yet many struggle to access even basic healthcare as rural hospitals close at record rates.Dr. Jennifer Schneider, co-founder and CEO of Homeward Health, is tackling this crisis head-on by reimagining how care is delivered to Medicare Advantage members in rural America. Drawing on her experiences as a physician, a patient with Type 1 diabetes, and the former president of Livongo, Jenny shares why rural healthcare is both a massive challenge and an untapped opportunity.We cover:

E31 | Business Leadership from a Doctor Who Enrolled in Medical Sales U

Medical Sales U with Dave Sterrett

Play Episode Listen Later Nov 24, 2025 25:38

Beyond the MD: Why a Johns Hopkins MBA Chose Medical Sales U (ft. Dr. Kevin Maggisano)What does it take to bridge the gap between clinical expertise and business execution? In this episode, we sit down with Dr. Kevin Maggisano, a professional who embodies the intersection of high-level medical vision and elite business strategy.Despite earning his MD from Western University and completing an MBA from Johns Hopkins, Dr. Maggisano believes that real leadership requires more than just degrees. It requires business clarity and strategic communication. That is exactly why he chose to enroll in Medical Sales U.In this episode, we cover:The Power of Continuous Growth: Why Dr. Maggisano believes leaders at every level, even those with MDs and MBAs, can still sharpen their business strategy and grow.Strategic Communication: How to move beyond clinical knowledge to master the art of communicating value and driving measurable results.Validating the Process: How Dr. Maggisano's experience reinforces the credibility and direction of Medical Sales U, proving that our focus on leadership and results works for top-tier professionals.Building a Career: Insights on how to build a rewarding career inside the medical sales world by combining medical authority with sales acumen.Dr. Maggisano's story is a powerful reminder that future leaders can trust the process. His voice amplifies our mission to help professionals identify their strengths and succeed in the competitive world of medical sales.About Dr. Kevin Maggisano: Dr. Maggisano combines deep medical insight with rigorous business training. He holds an MD from Western University and an MBA from Johns Hopkins University. He joined Medical Sales U to further strengthen his leadership skills and refine his approach to business strategy.Learn more about coaching and career support at https://medicalsalesu.com/

power building doctors mba md johns hopkins university johns hopkins validating business leadership western university mds enrolled medical sales

AI-Powered Population Management Reveals Surprising Risk Factors with Mike Hoxter Lightbeam Health Solutions TRANSCRIPT

Empowered Patient Podcast

Play Episode Listen Later Nov 24, 2025

Mike Hoxter, CTO of Lightbeam Health Solutions, is focused on applying AI to population health management by using predictive models to enhance risk stratification for organizations with value-based care contracts. He emphasizes the importance of integrating social determinants of health along with clinical data to create more accurate predictive scores for patient outcomes, such as reducing hospital readmissions. AI enables a model to incorporate diverse data to derive more fine-tuned, actionable predictions. Mike explains, "We're really all for optimization in value-based care plans and care management. That's really our bread and butter, which is a pretty wide net. So we have a lot of large provider organizations in either CMS MSSP, ACO REACH, or a wide range of value-based care contracts with a lot of the commercial players. The Blues, Humana, Cigna, and Aetna all have value-based care plans that they have contracts with providers. So, optimizing for performance in those contracts. Anybody who works within those is our main clientele. We also have payers that are administering value-based care plans and some hospital systems as well." "If you're good at preventative healthcare, you prevent a lot of unnecessary healthcare. And so risk stratification is something that we do a lot of, and we use a lot of the standard models out there. We have Johns Hopkins embedded into our application. We have all of the different HCC models for Medicare Advantage, CDPs for Medicaid, but then also we have a suite of internal machine-learning-based models, which, I think, is funny - we've gotten to a point where there's such a thing as traditional AI, which is what it's called." #LightbeamHealthSolutions #PopulationHealth #ValueBasedCare #VBC #VBCEnablement #AI #SDOH #RemotePatientMonitoring #Providers #Payers #ACO lightbeamhealth.com Listen to the podcast here

ai management blues surprising cto population medicaid humana johns hopkins ai powered risk factors medicare advantage aetna cigna hcc health solutions cdps aco reach

AI-Powered Population Management Reveals Surprising Risk Factors with Mike Hoxter Lightbeam Health Solutions

Empowered Patient Podcast

Play Episode Listen Later Nov 24, 2025 20:16

ai management blues surprising cto population medicaid humana johns hopkins ai powered risk factors medicare advantage aetna cigna hcc health solutions cdps aco reach

Why bad math (not ideology) is killing DPC clinics

The Podcast by KevinMD

Play Episode Listen Later Nov 22, 2025 16:50

Health care strategist Dana Y. Lujan discusses her article "Why direct primary care (DPC) models fail." Dana argues that the DPC community's obsession with "purity" is missing the point, stating that these models don't fail over ideology, they fail because of bad math. She uses the University of Houston's $1 million clinic failure as a prime example of a "fundamental market mismatch," where a DPC model was placed in a low-income area that couldn't sustain its membership fees (a ~70 percent revenue deficit). Dana also debunks the myth that institutions can't run successful DPC programs, citing CHI Health and Johns Hopkins as proof that financial sustainability and market fit are the true keys. This episode explores the critical difference between what's legally permissible and what's operationally sustainable, and why the DPC conversation must shift from philosophy to execution. Learn why you cannot "subscription-model your way out of poverty." Our presenting sponsor is Microsoft Dragon Copilot. Want to streamline your clinical documentation and take advantage of customizations that put you in control? What about the ability to surface information right at the point of care or automate tasks with just a click? Now, you can. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Offering an extensible AI workspace and a single, integrated platform, Dragon Copilot can help you unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise, and it's part of Microsoft Cloud for Healthcare, built on a foundation of trust. Ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

university health ai healthcare killing offering ease ideology johns hopkins clinics dpc microsoft cloud bad math

2025 D3 XC Nationals Instant Reaction

D3 Glory Days Podcast

Play Episode Listen Later Nov 22, 2025 25:43

While still in the studio Noah and Stu recap the D3 XC national meet and give their reactions to an awesome day in Spartanburg, SC.UW-La Crosse take home the team title for second year in a row and NYU take home the win for the women.Emmanuel Leblond of Johns Hopkins won on the men's side and Audrey Maclean of Middlebury won on the women's side.Support Bombas!A big thanks to Bombas for supporting D3 Glory Days for our regional coverage. If you've been enjoying the coverage, show some love to Bombas by using our code. Use code: GLORYDAYS21 for 21% off your first order ⁠⁠bombas.com⁠⁠How to Support D3 Glory Days:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠THE NEWSLETTER!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠D3 Glory Days Venmo⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠We launched a Patreon!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Subscribe and leave us a review on Apple Podcasts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠,⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Strava⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

nyu nationals johns hopkins strava instant reaction bombas spartanburg middlebury uw la crosse

TWiV 1272: Clinical update with Dr. Daniel Griffin

Small World, Big Problems

Play Episode Listen Later Nov 22, 2025 63:24

In his weekly clinical update, Dr. Griffin and Vincent Racaniello are dismayed by the changes on CDC vaccine website positively stating the link between autism and vaccination, the finding of wild type poliovirus 1 in Germany, Marburg virus in Ethiopia, decimation of the elephant breeding colony by H5N1 and the first human case of H5N5 influenza virus infection before Dr. Griffin deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, antibody escape by seasonal flu viruses, where to find PEMGARDA, how to access and pay for Paxlovid, long COVID treatment center, where to go for answers to your long COVID questions, if resistance exercise aids in recovery from long COVID and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Autism and Vaccines (CDC: Vaccine Safety) A new road to eradication- WPV 1 in Germany from Afghanistan (Reuters) Ethiopia confirms first outbreak of Marburg virus disease (WHO: Ethiopia) Highly Pathogenic Avian Influenza Viruses (HPAIV) Associated with Major Southern Elephant Seal Decline at South Georgia (Communications Biology) Avian flu has decimated world's largest breeding colony of southern elephant seals (CIDRAP) Washington resident is infected with a different type of bird flu (AP News) Pelagic Seabirds (OceanAminals) That sounds far away: Multiple transatlantic incursions of highly pathogenic avian influenza clade 2.3.4.4b A(H5N5) virus into North America and spillover to mammals (Cell Reports) Regional voices, different choices: Parents' and caregivers' HPV vaccine attitudes in the northeast and Southeast United States (Vaccine) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Measles (CDC Measles (Rubeola)) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: cliff notes (CDC FluView) ACIP Recommendations Summary (CDC: Influenza) Emergence of seasonal influenza A(H3N2) variants with immune escape potential warrants enhanced molecular and epidemiological surveillance for the 2025–2026 season (University of Toronto Press) Types of Influenza Viruses (CDC: Influenza (flu)) With an absent CDC and mismatched 'subclade K' flu strain, experts face upcoming season with uncertainty (CIDRAP) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season(FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Long-term impact of nirsevimab on prevention of respiratory syncytial virus infection using a real-word global database (Journal of Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Estimating Risk of Guillain-Barré Syndrome in US Medicare-Enrolled Older Adults Following Medically Attended Respiratory Syncytial Virus Disease (CID) FDA Requires Guillain-Barré Syndrome (GBS) Warning in the Prescribing Information for RSV Vaccines Abrysvo and Arexvy: FDA Safety Communication (FDA) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) COVID-19 vaccination is associated with reduced complications in pediatric patients with atopic dermatitis (Annals of Allergy, Asthma and Immunology) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) Risk mitigation of shared room ventilation and filtration on SARS-CoV-2 transmission: a multicenter test-negative study (Infection Control and Hospital Epidemiology) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Resistance Exercise Therapy After COVID-19 Infection(JAMA Open Network) Reaching out to US house representative Letters read on TWiV 1272 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

National Security Business: How to Get Started

Play Episode Listen Later Nov 21, 2025 66:46

Sanjana Polapragada hosts a two-speaker conversation with Robert Miller, a seasoned “startup statesman” who has advised companies such as CrowdAI (now acquired by Saab) and Hawkeye 360 (now valued at over a billion dollars), and Emma Bates, CEO and founder of Cachai, a dual-use tech company (for both civilian and military purposes) focused on collaborative autonomy and drone innovation in the national security space. Together, they unpack how to navigate the national security startup ecosystem, secure government contracts, and cross the many “valleys of death” that mission-driven ventures face. Aimed at anyone with a concrete, government-focused venture idea, the episode offers practical how-tos for entering and thriving in the field. If you're curious about building a mission-driven venture in national security, this episode is your starting point. Produced in partnership with the Pava Center for Entrepreneurship at Johns Hopkins.Researched and hosted by Sanjana Polapragada; edited by Vishal Gogusetti.

ceo entrepreneurship get started hawkeyes national security johns hopkins aimed saab researched robert miller emma bates

Dr. Jessica Pryce on the Harms of the Child Welfare System

Nobody Should Believe Me

Play Episode Listen Later Nov 20, 2025 42:29

In light of the overturned ruling of Kowalski v Johns Hopkins and Serial's The Preventionist, we're reairing an episode from our Kowalski season in which Andrea dives into the complexities around reporting child abuse suspicions. *** With the jury's stunning $242 million verdict in favor of the Kowalski family, host Andrea Dunlop looks at why this case has struck such a nerve on both sides of the political spectrum. She examines why some mothers accused of medical child abuse are viewed as monsters and others as martyrs. Andrea looks at the charges against social worker Cathy Bedy the woman who became the face of the child welfare bureaucracy during the Maya Kowalski case and examines her testimony. We also seek out answers about the troubled state of child welfare in America by talking to Dr. Jessica Pryce, author of the forthcoming book Broken: Transforming Child Protective Services—Notes of a Former Caseworker. Dr. Pryce shares heart-wrenching stories of mothers whose lives have been turned upside down by investigations and sets out a compelling and urgent case for an overhaul of CPS. With her inside view of the system, she also gives insight on how doctors and other mandated reporters can do the best for the families they want to help even within the current, deeply flawed system. This episode grapples with the complexity around reporting child abuse suspicions and the potentially chilling ripple effects of the explosive verdict in Kowalski v Johns Hopkins All Childrens. It examines the lack of support for struggling parents in America, while leaving the listener with urgent questions about justice and equity. *** Learn more about Dr. Pryce's work on her website: https://jessicaprycephd.com/ Tickets for Nobody Should Believe Me LIVE: https://www.andreadunlop.net/nobody-should-believe-me-live Order Andrea's book The Mother Next Door: Medicine, Deception, and Munchausen by Proxy. Click here to view our sponsors. Remember that using our codes helps advertisers know you're listening and helps us keep making the show! Subscribe on YouTube where we have full episodes and lots of bonus content. Follow Andrea on Instagram: @andreadunlop Buy Andrea's books here. For more information and resources on Munchausen by Proxy, please visit MunchausenSupport.com The American Professional Society on the Abuse of Children's MBP Practice Guidelines can be downloaded here. Learn more about your ad choices. Visit podcastchoices.com/adchoices

america children tickets abuse deception serial johns hopkins proxy harms cps kowalski munchausen pryce child welfare system andrea dunlop maya kowalski

Nick Queensland: Change Management in FM

The Modern Facilities Management Podcast

Play Episode Listen Later Nov 20, 2025 27:06

In this episode of The Modern Facilities Management Podcast, Griffin Hamilton sits down with Nick Queensland, a a healthcare facilities leader with more than 25 years of experience at Mayo Clinic, Luminis Health, and Johns Hopkins. Griffin and Nick dig into the realities of change management in hospital facilities—why buy-in matters, how to communicate effectively with stakeholders, and why reinforcing change is just as important as implementing it. Nick also reflects on the evolving expectations in healthcare facilities and the importance of engaging teams at every level.If you're looking to grow your career or lead change in facilities management, this episode is packed with practical insights and hard-earned lessons.Key Topics CoveredNavigating a 25+ year career in hospital facilitiesThe importance of understanding your role in healthcareLeadership philosophies and developing future FM talentChange management: buy-in, communication, and reinforcementEngaging stakeholders across clinical and non-clinical teamsHow expectations in hospital facilities have evolvedBuilding team culture during times of changeEnjoy!

queensland mayo clinic change management johns hopkins

Two Paths, One Night: The Murder of Jayna Murray

Murder In The Black

Play Episode Listen Later Nov 20, 2025 32:22

SUMMARY:In today's episode, Steph takes listeners deep into one of the most shocking workplace murders in recent history — the Lululemon case. This story follows the lives of Jayna Murray and Brittany Norwood, two women who started life on remarkably similar paths: athletic, ambitious, intelligent, and deeply loved. But as adulthood unfolded, their journeys diverged dramatically.Jayna lived a life full of adventure, discipline, and exploration — from her childhood in Australia to her graduate studies at Johns Hopkins. Brittany, once a standout soccer star with a promising future, quietly battled an impulse she never confronted: a cycle of compulsive stealing that grew more dangerous over time.On March 12, 2011, those two paths collided inside a Lululemon store in Bethesda, Maryland.Listeners will hear:Jayna's international upbringing, athletic excellence, academic brilliance, and deep devotion to her familyBrittany's competitive childhood, collegiate soccer career, and the long-standing pattern of theft that followed her into adulthoodA detailed breakdown of the crime scene and Brittany's initial account of the attackThe investigation's early focus on an unrelated suspect, Keith Lockett, and how detectives ultimately cleared himThe disturbing inconsistencies that led police to re-examine Brittany's storyThe emotional second interview, including the pivotal moment Brittany's brother confronted herThe psychological insight behind kleptomania—why the urge to steal can become an addictionThe truth about the altercation between Jayna and Brittany that nightHow Brittany staged the scene, lied, and ultimately confessedThe heartbreaking details of Jayna's injuries and the trial that followedThis episode explores:How compulsive behaviors, when left untreated, can escalate into tragedyThe consequences of avoidance, secrecy, and escalating bad choicesThe systemic failure of Lululemon to address repeated employee misconductHow confrontation — especially over conduct long hidden — can trigger catastrophic outcomesThe bravery of Jayna Murray and the life she deserved to continue livingSteph closes the episode with a powerful discussion on how we often trivialize stealing as harmless or childish — when in reality, it can become its own addiction cycle. Brittany's reluctance to get help or face consequences created a storm she could no longer outrun, and Jayna lost her life because of it. This tragedy stands as a reminder that ignoring patterns doesn't erase them… it allows them to grow.-----------------------------------------------------------------Giveaway Instructions Subscribe to the Murder in the Black YouTube channel.Choose any video on our channel and leave a comment.That's it — you're entered!The giveaway closes November 30th, so don't wait — jump in now!LINK BELOW⁠https://youtube.com/@murderintheblack?si=cr03m4ITJTzz01qX⁠Sources for This Episode:The Washington Post – In-depth reporting on the Lululemon murder, trial transcripts, and investigative findings.ABC News – Coverage of Brittany Norwood's arrest, trial, and details surrounding theft allegations and motive.NBC Washington – Local reporting from 2011 including interviews, community statements, and crime-scene updates.The Baltimore Sun – Reporting on Brittany Norwood's confession, trial proceedings, and sentencing.Montgomery County Court Records – Trial filings, witness statements, and verdict documentation from State of Maryland v. Brittany Norwood

australia state murder maryland bethesda one night lululemon johns hopkins two paths storythe jayna himthe herthe jayna murray addictionthe brittany norwood

DESI EM PROJECT - EPISODE 161 - THE ONE WITH "TYPE 1 DIABETES MASTERCLASS WITH DR ANDREW KOUTNIK"

THE DESI EM PROJECT

Play Episode Listen Later Nov 19, 2025 51:15

Andrew Koutnik, PhD, is an award-winning scientist committed to producing and translating cutting-edge research into real world solutions for health, disease management, and performance optimization. Specializing in type 1 diabetes and metabolic health, Andrew has worked with renowned institutions such as Harvard, Johns Hopkins, NASA, and the Department of Defense to develop actionable, evidence-based strategies for overcoming complex health challenges.Drawing from his personal experience living with Type 1 Diabetes and his scientific expertise, Andrew guides individuals to take control of their health through practical, customized approaches. He is passionate about helping people understand how their bodies respond to nutrition, exercise, and lifestyle changes, enabling them to thrive, whether managing disease or optimizing performance.In this episode, Andrew speaks about his journey and experiences delving into ketosis, exogenous ketones, pregnancies, cancers and much more. We will definitely look forward to having him again! Visit his website - https://andrewkoutnik.com/IG - @andrewkoutnikphdX - @AKoutnikLinkedIn - Andrew Koutnik

phd project drawing harvard nasa defense masterclass diabetes specializing johns hopkins desi type1 type 1 diabetes

#75: Clinical Pearls from David Roberts and Dr. John Gildea (from Mara Labs): Stabilizing Sulforaphane—Inside the Creation and Science of a Powerful Cancer-Fighting Compound

The Clinician's Corner

Play Episode Listen Later Nov 18, 2025 9:22

For this week's episode of the Clinician's Corner, we've gone into the archives to pull out another clinical pearl from one of our favorite episodes - and today we discuss the powerful healing properties of sulforaphane with David Roberts & Dr. John Gildea, from Mara Labs. This interview first aired in 2023, and the full interview can be viewed here. Clinical pearls we extracted from the original interview: The story behind BrocElite, a stabilized sulforaphane supplement The motivation behind the research The scientific background on sulforaphane (e.g., its development and stabilization) How sulforaphane plays a role in cancer and chemotherapy The Clinician's Corner is brought to you by the Institute of Restorative Health. Follow us: https://www.instagram.com/instituteofrestorativehealth/ Connect with Mara Labs: Website: https://mara-labs.com/ Instagram: https://www.instagram.com/themaralabs/?hl=en Facebook: https://www.facebook.com/themaralabs/ Speaker bios: David Roberts holds a MPH from Johns Hopkins, a Masters in BME from the UVA, and a Bachelors in EE and BME from Duke. David has more than 20 years of public health experience on three continents. In 2014 David cofounded the gut supplement, RESTORE, now called ION. Dr. John Gildea is Cell Pathophysiologist and Molecular Geneticist with 33 years of scientific research experience at the bench in both industrial and academic labs. A guiding principle of his work is to establish innovative optimized model systems and assays in order to robustly investigate both normal and pathological states. He has extensive expertise establishing and investigating in-vivo, ex-vivo, primary and immortalized cell culture systems, molecular biology, antibody based and nucleic acid based diagnostic assay development, electron and fluorescence microscopy and flow cytometry. Dr. Gildea has published 63 peer reviewed articles, 3 book chapters, 3 reviews, 3 patents, and has 3173 citations. Keywords: functional health, sulforaphane, broccoli, breast cancer, oncology, chemosensitizer, glucoraphanin, myrosinase, supplement, restorative health, anti cancer, clinical skills, chronic disease, cancer models, NRF2, antioxidant system, chemotherapy, metastasis, Mara Labs, Baroque Elite, broccoli sprouts, juicing, practitioner training, case studies, gastrointestinal healing, functional medicine, curriculum, certification, clinical mastery, immune system, detoxification Disclaimer: The views expressed in the IRH Clinician's Corner series are those of the individual speakers and interviewees, and do not necessarily reflect the views of the Institute of Restorative Health, LLC. The Institute of Restorative Health, LLC does not specifically endorse or approve of any of the information or opinions expressed in the IRH Clinician's Corner series. The information and opinions expressed in the IRH Clinician's Corner series are for educational purposes only and should not be construed as medical advice. If you have any medical concerns, please consult with a qualified healthcare professional. The Institute of Restorative Health, LLC is not liable for any damages or injuries that may result from the use of the information or opinions expressed in the IRH Clinician's Corner series. By viewing or listening to this information, you agree to hold the Institute of Restorative Health, LLC harmless from any and all claims, demands, and causes of action arising out of or in connection with your participation. Thank you for your understanding.

How a Full Body MRI Gives You Answers, Not Anxiety with Dr. Dan Durand

The Daily Apple Podcast

Play Episode Listen Later Nov 18, 2025 41:18

Send us a textWhole body MRI is changing prevention from a guess into something you can actually see. Dr. Kevin White talks with Dr. Dan Durand, Johns Hopkins trained radiologist and Chief Medical Officer at Prenuvo, about how full body scans are catching silent problems early: from fatty liver and visceral fat to aneurysms, early cancers, and brain changes linked to cognitive decline and dementia. They unpack how Prenuvo's model pairs deep imaging, multiomic data, and real conversations with clinicians so patients do not just get a data dump, but a clear plan for what to do next.“Think of a whole body MRI as a home inspection for your health: you want to find the hidden leaks before the ceiling caves in.” – Dr. Dan DurandYou'll hear: • Why traditional screening only looks at a few organs and what whole body MRI adds • How often Prenuvo finds serious issues early and what that means for real people • The link between visceral fat, brain volume, and long term cognitive health • How AI is being used to measure brain regions, muscle, and fat with precision • Why reassurance from a clean scan can be just as powerful as a life saving catch • How to think about timing, HSA dollars, and making this part of your prevention planLearn more about Prenuvo and their whole body MRI at prenuvo.com.

anxiety longevity mri chief medical officers brain health johns hopkins durand hsa full body reassurance metabolic health cognitive decline body composition early detection health anxiety kevin white visceral fat prenuvo

Pathology with Dr. Priya | A Routine Repair. A Live Wire. A Fatal Shock.

Play Episode Listen Later Nov 17, 2025 18:32 Transcription Available

Electrocution can be silent and sudden, leaving few external signs and limited clues without careful investigation. This week on Pathology with Dr. Priya, a Zone 7 series, Sheryl McCollum and Dr. Priya Banerjee explain how electrical current travels through the body, why the heart can stop in an instant, and what pathologists look for at the entry and exit points of a shock. They discuss real-world risks, from downed power lines to home repairs, and the safety measures that can prevent fatal accidents. Highlights • (0:00) Sheryl welcome listeners and introduces the topic of electrocution deaths • (2:00) Entry and exit points: irregular burn and blister patterns on hands, feet, or other points of contact • (3:30) How electrical current disrupts the heart’s rhythm and can lead to sudden death • (6:00) Who is more vulnerable: pre-existing heart conditions and age can increase susceptibility to fatalarrhythmia • (8:15) Storm damage, downed lines, and why no one should move live wires • (10:45) “Weekend warrior” risks and everyday household hazards • (15:15) What electrocution looks like internally: tissue damage, muscle breakdown, and organ findings • (17:30) Seasonal reminders: holiday lights, wet environments, and the importance of hiring professionals forelectrical work About the Hosts Dr. Priya Banerjee is a board-certified forensic pathologist with extensive experience in death investigation, clinical forensics, and courtroom testimony. A graduate of Johns Hopkins, she served for over a decade as Rhode Island’s state medical examiner and now runs a private forensic pathology practice. Her work includes military deaths, and high-profile investigations. Dr. Priya has also been featured as a forensic expert on platforms such as CrimeOnline and Crime Stories with Nancy Grace. She is a dedicated educator, animal lover, and proud mom. Website: anchorforensicpathology.com Twitter/X: @Autopsy_MD Sheryl McCollum is an Emmy Award–winning CSI, a writer for CrimeOnline, and the Forensic and Crime Scene Expert for Crime Stories with Nancy Grace. She works as a CSI for a metro Atlanta Police Department and is the co-author of the textbook Cold Case: Pathways to Justice. Sheryl is also the founder and director of the Cold Case Investigative Research Institute (CCIRI), a nationally recognized nonprofit that brings together universities, lawenforcement, and experts to help solve unsolved homicides, missing persons cases, and kidnappings. Email: coldcase2004@gmail.com Twitter/X: @ColdCaseTips Facebook: @sheryl.mccollum Instagram: @officialzone7podcast If this episode provided clarity on electrocution deaths and scene safety, share it with a friend and leave areview. Your support helps others discover the science, the stories, and the heart behind Pathology with Dr. Priya | A Zone 7 Series.See omnystudio.com/listener for privacy information.

TWiV 1270: Clinical update with Dr. Daniel Griffin

turning heads johns hopkins diii

Play Episode Listen Later Nov 15, 2025 50:56

In his weekly clinical update, Dr. Griffin and Vincent Racaniello record from the ASTMH meeting in Toronto and discuss continuing avian flu outbreaks, the continued global measles outbreak, the effectiveness of high and low doses of the influenza vaccine before Dr. Griffin deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, children hospitalizations following COVID-19 and influenza vaccination, where to find PEMGARDA, how to access and pay for Paxlovid, long COVID treatment center, where to go for answers to your long COVID questions, and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Five new avian flu outbreaks confirmed in ducks, turkeys in 3 US states (CIDRAP) Confirmation of highly pathogenic Avian Influenza in Commercial and Backyard flocks (USDA: Animal and Plant Health Inspection Service) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Measles (CDC Measles (Rubeola)) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) ACIP Recommendations Summary (CDC: Influenza) Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD) (LANCET) Relative effectiveness of the high-dose versus standard-dose influenza vaccines for the prevention of laboratory-confirmed influenza among Italian older adults during three recent seasons (International Journal of Infectious Diseases) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season (FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Long-term impact of nirsevimab on prevention of respiratory syncytial virus infection using a real-word global database (Journal of Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) COVID-19 and influenza deaths in Australian children 2018-2023: a national case analysis (Journal of Pediatric Infectious Diseases Society) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Reaching out to US house representative Letters read on TWiV 1270 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

23.3: Turning Heads

Hoopsville

Play Episode Listen Later Nov 13, 2025 142:07

The basketball season has begun and soon all teams will have played their first game. Already there are upsets, surprises, and games of note. And while one shouldn't put too much stock in the early results (we still have more than 15 weeks of the season remaining), there are some things already turning heads. On Thursday's Hoopsville, we chat with a few programs who have already clearly stated they are going to be teams to contend with this season. And with others whose schedules could prove to be daunting or significant in a few months. Plus, there is still plenty of news items to catch up on from the off-season, pre-season, and start of season. Guests appearing on the Hudl Hoopsville Hotline: - Rodney Rogan, No. 8 Johns Hopkins women's coach - Klay Knueppel, Wisconsin Lutheran women's coach - Dave Macedo, No. 14 Virginia Wesleyan men's coach - Bill Sall, No. 12 Calvin men's coach Plus hear from the head of DIII men's officials about what he thinks is the biggest rule change for this season. Hoopsville is presented by D3hoops.com from the WBCA Studio.

AA237 - 23 Business Models Everyone Should Know, Part 1 of 2

Arguing Agile Podcast

Play Episode Listen Later Nov 13, 2025 90:25 Transcription Available

12 proven business models that separate successful products from failures!Product Manager Brian Orlando & Enterprise Business Agility Consultant Om Patel examine 12 real-world business models with real examples of the companies that employ them!Based on "The Art of Profitability" by Adrian Slywotzky (2002), this part-1-of-2 podcast covers:• Customer Solution Model (Palantir, SAP, Salesforce)• Product Pyramid (Apple, Tesla, GM)• Multi-Component Pricing (Uber, Coca-Cola)• Switchboard Platforms (Uber, Airbnb, eBay)• Time & Materials (Consulting firms)• Blockbuster Model (Pharma, Netflix)• Profit Multiplier (Microsoft, Disney)• Entrepreneurial Model• Specialist Model (Mayo Clinic, Agile Coaches)• Installed Base (Printers, Razors, K-Cups)• De Facto Standard (Windows, Adobe PDF)• Brand Model (Apple, Nike, BMW)Perfect for product managers, agile coaches, startup founders, and business leaders trying to understand which revenue model fits their product strategy.

Profit, Prejudice and the Price of Care

Progressive Voices

Play Episode Listen Later Nov 12, 2025 15:23

This time on Code WACK! How do health insurance hassles like denials and preauthorizations exacerbate inequities in our broken healthcare system? How do they rob physicians of precious time caring for patients and even jeopardize their practices? And why are some big insurance companies buying up physician practices? To find out, we recently spoke with Dr. Erica Rowe Urquhart, a private practice orthopedic surgeon in northern New Jersey. Harvard-trained in biomedical engineering with an MD and PhD from Johns Hopkins, Dr. Urquhart is the author of the forthcoming book The Invisible Hand Wielding the Scalpel: Paying the Price in America's Fractured Healthcare System. This is the second episode of a two-part series. Check out the Transcript and Show Notes for more! And please keep Code WACK! on the air with a tax-deductible donation.

america care phd new jersey price harvard md profit prejudice johns hopkins urquhart

From PICU Trailblazer To Simulation Leader: Tonya Schneidereith On Innovation, Teaching, And Safe Practice

The Sim Cafe~

Play Episode Listen Later Nov 12, 2025 23:58 Transcription Available

Send us a textWhat does it take to build safer clinicians, not just better test takers? We sit down with pediatric critical care pioneer and simulation leader Tonya Schneidereith to trace a career defined by curiosity, courage, and a relentless focus on patient safety. From early days as one of the first PICU nurse practitioners in the country to associate director of simulation at Johns Hopkins, Tonya reveals how mentorship, research, and design thinking shaped her approach to teaching and assessment.We dig into her medication safety work using Google Glass to capture the learner's point of view, exposing why accurate math still leads to dangerous IV pump programming when context is missing. That insight led to national recommendations on verifying dosage calculation competence and a sharper focus on debriefing. Tanya shares a memorable morphine case where most learners turned up oxygen as ventilation failed, and how a single probing question in debrief uncovered the real driver behind a “correct” action. The lesson is clear: simulation must illuminate decision-making, not just outcomes.Tonya also opens the doors to SIMPL Simulation, the consultancy she co-founded to elevate faculty development, program design, and simulation operations. She walks us through a bold project with BSA LifeStructures and Wake Tech Community College: a true simulation hospital spanning EMS arrival, diagnostics, acute care rooms, an operating room, and a live MRI. It's a blueprint for interprofessional education that makes teamwork the default. We then explore responsible AI in healthcare simulation, drawing on a new white paper Tonya helped shape. Ethical integration, transparent limits, and scenario design that builds judgment are essential as AI becomes part of daily clinical work.If you care about better debriefing, safer medication practices, AI in nursing education, and simulation spaces that teach as powerfully as people do, this conversation will sharpen your approach. Listen, share with your team, and tell us the one change you'll make in your next sim. Subscribe for more expert stories and leave a review to help others find the show.Innovative SimSolutions.Your turnkey solution provider for medical simulation programs, sim centers & faculty design.

ai practice teaching innovation leader safe iv ethical mri simulation ems johns hopkins trailblazer google glass picu wake tech community college

Dr. Shin Lin - The Science of Acupuncture

Somatic Primer Podcast

Play Episode Listen Later Nov 10, 2025 61:39

On today's episode I once again had the pleasure to speak to Dr. Shin Lin. Shin Lin, PhD, is a world-renowned expert on Tai Chi and a 12th generation heir of Chen Style Tai Chi designated by Grandmaster Chen Zheng-Lei of China's Chen Family Village, where Tai Chi originated.He is a longtime chair of biophysics at Johns Hopkins and professor of biological sciences and biomedical engineering at UCI, where his Laboratory for Mind-Body Signaling and Energy Research applies modern biophysical technologies to study the benefits of Tai Chi/Qigong on mind-body functions and body energy measured as heat, light and electricity. The result of his studies, are used to formulate models to explain the beneficial effects of these practices on health and healing at the cellular, and molecular levels.You can checkout his research @ Department of Cell Biology Please visit Somatic Primer:You can visit at our website: Somaticprimer.comFor upcoming live courses: Vidyamethod.comOur Online Learning Platform @ Somatic Primer on PatreonPlease consider supporting the show with a monthly donation and don't to forget to like and subscribe.Support the show

china science phd acupuncture johns hopkins laboratory shin tai chi comfor uci energy research tai chi qigong

Creating a Holiday Stress Plan

The Mental Breakdown

Play Episode Listen Later Nov 9, 2025 29:26

Welcome to The Mental Breakdown and Psychreg Podcast! Today, Dr. Berney and Dr. Marshall discuss the importance of creating a plan for the holidays to reduce holiday stress. Read the articles from Johns Hopkins here, from UC Davis here, and from Catawba Valley Healthcare here. You can now follow Dr. Marshall on twitter, as well! Dr. Berney and Dr. Marshall are happy to announce the release of their new parenting e-book, Handbook for Raising an Emotionally Healthy Child Part 2: Attention. You can get your copy from Amazon here. We hope that you will join us each morning so that we can help you make your day the best it can be! See you tomorrow. Become a patron and support our work at http://www.Patreon.com/thementalbreakdown. Visit Psychreg for blog posts covering a variety of topics within the fields of mental health and psychology. The Parenting Your ADHD Child course is now on YouTube! Check it out at the Paedeia YouTube Channel. The Handbook for Raising an Emotionally Health Child Part 1: Behavior Management is now available on kindle! Get your copy today! The Elimination Diet Manual is now available on kindle and nook! Get your copy today! Follow us on Twitter and Facebook and subscribe to our YouTube Channels, Paedeia and The Mental Breakdown. Please leave us a review on iTunes so that others might find our podcast and join in on the conversation!

amazon raising attention handbook johns hopkins uc davis holiday stress mental breakdown behavior management berney

TWiV 1268: Clinical update with Dr. Daniel Griffin

children hospitals tickets abuse deception shapiro johns hopkins proxy overturned kowalski munchausen

Play Episode Listen Later Nov 8, 2025 51:37

In his weekly clinical update, Dr. Griffin with Vincent Racaniello discusses the link between in utero SARS-CoV-2 infection and poor neurodevelopment outcomes, the use of an mRNA vaccine as an anti-cancer therapy, why one should receive the HPV vaccine, asymptomatic H5N1 isolations in humans, and H5N1 on turkey farms, before Dr. Griffin deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, how two vaccinated physicians became infected with measles, effective of COVID-19 vaccine for children, where to find PEMGARDA, how to access and pay for Paxlovid, can you be retreated with Paxlovid, long COVID treatment center, where to go for answers to your long COVID questions, how a specific antibody type may associate with recovery from long COVID, if use of a probiotic is helpful to treat mild COVID-19, if vaccination helps prevent long in adolescents and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Neurodevelopmental Outcomes of 3-Year-Old Children Exposed to Maternal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Utero (Obstetrics & Gynecology) SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade (Nature) TWiV 1267: A cancer vaccine and an mpox treatment (microbeTV: TWiV1267) Cancers Caused by HPV (CDC: Human papillomavirus (HPV)) Circulating tumor human papillomavirus DNA whole genome sequencing enables human papillomavirus-associated oropharynx cancer early detection (Journal of National Cancer Institute) Impact of Vaccinating Adult Women Who Are HPV-Positive or with Confirmed Cervical SIL with the 9-Valent Vaccine (Viruses) ACIP Shared Clinical Decision-Making Recommendations (CDC: Advisory Committee on Immunization Practices (ACIP)) HPV Vaccination Recommendation (CDC: Vaccines & Immunizations) Asymptomatic Human Infections With Avian Influenza A(H5N1) Virus Confirmed by Molecular and Serologic Testing (JAMA: OPEN Network) Review: Human H5N1 avian flu cases can be asymptomatic, and the virus likely spreads among people (CIDRAP) Avian flu strikes turkey farms in Dakotas, large egg facility in California (CIDRAP) Another Doctor at Ichilov Contracts Measles After Treating Unvaccinated Child (gov.il) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Measles (CDC Measles (Rubeola)) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) ACIP Recommendations Summary (CDC: Influenza) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season (FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Vascular and inflammatory diseases after COVID-19 infection and vaccination in children and young people in England (LANCET: Child & Adolescent Health) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Real-World Effectiveness of Nirmatrelvir-Ritonavir in Preventing Coronavirus Disease 2019–Associated Hospitalization (CID) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID SARS-CoV-2 spike-specific IgG4 class switching associates with clinical recovery in Long COVID (Journal of Infection) Efficacy of Lactococcus lactis Strain Plasma in Patients with Mild COVID-19 (Infectious Diseases and Therapy) Preventive effect of vaccination on long COVID in adolescents with SARS-CoV-2 infection (Vaccine) Reaching out to US house representative Letters read on TWiV 1268 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Kowalski v Johns Hopkins overturned with Ethen Shapiro

Nobody Should Believe Me

Play Episode Listen Later Nov 6, 2025 57:50

In this episode, Andrea sits down with Ethen Shapiro, trial counsel for Johns Hopkins All Children's Hospital, to unpack the landmark appellate decision overturning the $200 million verdict in the Kowalski v. Johns Hopkins case. Ethen explains how the ruling reinforces the immunity given to mandatory reporters acting in good faith when reporting suspected abuse. Together, they explore how the decision challenges the “medical kidnapping” narrative and clarifies that the hospital's actions were guided by law and necessity, not malice. The discussion also highlights what this ruling could mean for similar cases nationwide, where lawsuits against hospitals and social workers are on the rise. *** Tickets for NSBM Live - Seattle 3.18.26 https://tickets.thetripledoor.net/eventperformances.asp?evt=2181 Order Andrea's book The Mother Next Door: Medicine, Deception, and Munchausen by Proxy. Click here to view our sponsors. Remember that using our codes helps advertisers know you're listening and helps us keep making the show! Subscribe on YouTube where we have full episodes and lots of bonus content. Follow Andrea on Instagram: @andreadunlop Buy Andrea's books here. For more information and resources on Munchausen by Proxy, please visit MunchausenSupport.com The American Professional Society on the Abuse of Children's MBP Practice Guidelines can be downloaded here. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Poisoned by Love: The Eye-Drop Murder of a Retire Police Chief